Terence Ketter

Publications

• Recovery in bipolar depression: Post-hoc analysis of a placebo-controlled lurasidone trial followed by a long-term continuation study.
  Loebel, A., Siu, C., Rajagopalan, K., Pikalov, A., Cucchiaro, J., & Ketter, T. A. (2015). Recovery in bipolar depression: Post-hoc analysis of a placebo-controlled lurasidone trial followed by a long-term continuation study. Journal of affective disorders, 186, 376-382.
• Clinical Observations About The Strange Case of Dr. Jekyll and Mr. Hyde in Relation to Bipolar Disorder.
  Dell'Osso, B., & Ketter, T. A. (2015). Clinical Observations About The Strange Case of Dr. Jekyll and Mr. Hyde in Relation to Bipolar Disorder. Academic psychiatry , 39(5), 607-608.
• Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder
  Ketter, Ta., Yang, R., & Frye, M. A. (2015). Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder. JOURNAL OF AFFECTIVE DISORDERS, 181, 87-91.
• Pharmacotherapy for bipolar depression: comparative efficacy and acceptability is in the eye of the beholder. Citrome, L., & Ketter, T. A. (2015). Pharmacotherapy for bipolar depression: comparative efficacy and acceptability is in the eye of the beholder. Evidence-based mental health, 18(3), 88-?.
  
• Childhood-compared to adolescent-onset bipolar disorder has more statistically significant clinical correlates Holtzman, J. N., Miller, S., Hooshmand, F., Wang, P. W., Chang, K. D., & Ketter, T. A. (2015). Childhood-compared to adolescent-onset bipolar disorder has more statistically significant clinical correlates. JOURNAL OF AFFECTIVE DISORDERS, 179, 114-120.
  
• Treating Insomnia Improves Mood State, Sleep, and Functioning in Bipolar Disorder: A Pilot Randomized Controlled Trial Harvey, A. G., Soehner, A. M., Kaplan, K. A., Hein, K., Lee, J., & Buysse, D. J. (2015). Treating Insomnia Improves Mood State, Sleep, and Functioning in Bipolar Disorder: A Pilot Randomized Controlled Trial. JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 83(3), 564-577.
  
• An exploratory study of responses to low-dose lithium in African Americans and Hispanics Arnold, J. G., Salcedo, S., Ketter, T. A., Calabrese, J. R., Rabideau, D. J., & Bowden, C. L. (2015). An exploratory study of responses to low-dose lithium in African Americans and Hispanics. JOURNAL OF AFFECTIVE DISORDERS, 178, 224-228.
  
• Psychotherapy use in bipolar disorder: Association with functioning and illness severity. Sylvia, L. G., Thase, M. E., Reilly-Harrington, N. A., Salcedo, S., Brody, B., & Deckersbach, T. (2015). Psychotherapy use in bipolar disorder: Association with functioning and illness severity. Australian and New Zealand journal of psychiatry, 49(5), 453-461.
  
• Assessing Cognitive Function in Bipolar Disorder: Challenges and Recommendations for Clinical Trial Design Burdick, K. E., Ketter, T. A., Goldberg, J. F., & Calabrese, J. R. (2015). Assessing Cognitive Function in Bipolar Disorder: Challenges and Recommendations for Clinical Trial Design. JOURNAL OF CLINICAL PSYCHIATRY, 76(3), E342-E350.
  
• Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE). Sylvia, L. G., Shelton, R. C., Kemp, D. E., Bernstein, E. E., Friedman, E. S., & Calabrese, J. R. (2015). Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE). Bipolar disorders, 17(2), 212-223.
  
• Complexity of illness and adjunctive benzodiazepine use in outpatients with bipolar I or II disorder: results from the Bipolar CHOICE study. Bobo, W. V., Reilly-Harrington, N. A., Ketter, T. A., Brody, B. D., Kinrys, G., & Kamali, M. (2015). Complexity of illness and adjunctive benzodiazepine use in outpatients with bipolar I or II disorder: results from the Bipolar CHOICE study. Journal of clinical psychopharmacology, 35(1), 68-74.
  
• Bipolar therapeutics update 2014: A tale of 3 treatments. Ketter, T. A., Wang, P. W., & Miller, S. (2015). Bipolar therapeutics update 2014: A tale of 3 treatments. journal of clinical psychiatry, 76(1), 69-70.
  
• Distinguishing Bipolar Disorder From Other Psychiatric Disorders in Children Singh, M. K., Ketter, T., & Chang, K. D. (2014). Distinguishing Bipolar Disorder From Other Psychiatric Disorders in Children. CURRENT PSYCHIATRY REPORTS, 16(12).
  
• The prevalence and burden of bipolar depression. Miller, S., Dell'Osso, B., & Ketter, T. A. (2014). The prevalence and burden of bipolar depression. Journal of affective disorders, 169, S3-11.
  
• Balancing benefits and harms of treatments for acute bipolar depression Ketter, T. A., Miller, S., Dell'Osso, B., Calabrese, J. R., Frye, M. A., & Citrome, L. (2014). Balancing benefits and harms of treatments for acute bipolar depression. JOURNAL OF AFFECTIVE DISORDERS, 169, S24-S33.
  
• Balancing benefits and harms of treatments for acute bipolar depression. Ketter, T. A., Miller, S., Dell'Osso, B., Calabrese, J. R., Frye, M. A., & Citrome, L. (2014). Balancing benefits and harms of treatments for acute bipolar depression. Journal of affective disorders, 169, S24-33.
  
• The effect of personalized guideline-concordant treatment on quality of life and functional impairment in bipolar disorder Sylvia, L. G., Rabideau, D. J., Nierenberg, A. A., Bowden, C. L., Friedman, E. S., & Reilly-Harrington, N. (2014). The effect of personalized guideline-concordant treatment on quality of life and functional impairment in bipolar disorder. JOURNAL OF AFFECTIVE DISORDERS, 169, 144-148.
  
• The prevalence and burden of bipolar depression Miller, S., Dell'Osso, B., & Ketter, T. A. (2014). The prevalence and burden of bipolar depression. JOURNAL OF AFFECTIVE DISORDERS, 169, S3-S11.
  
• Differential abnormalities of functional connectivity of the amygdala and hippocampus in unipolar and bipolar affective disorders Benson, B. E., Willis, M. W., Ketter, T. A., Speer, A., Kimbrell, T. A., & Post, R. M. (2014). Differential abnormalities of functional connectivity of the amygdala and hippocampus in unipolar and bipolar affective disorders. JOURNAL OF AFFECTIVE DISORDERS, 168, 243-253.
  
• Efficacy and Safety of Adjunctive Armodafinil in Adults With Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial Calabrese, J. R., Frye, M. A., Yang, R., & Ketter, T. A. (2014). Efficacy and Safety of Adjunctive Armodafinil in Adults With Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. JOURNAL OF CLINICAL PSYCHIATRY, 75(10), 1054-?.
  
• A novel application of the Intent to Attend assessment to reduce bias due to missing data in a randomized controlled clinical trial Rabideau, D. J., Nierenberg, A. A., Sylvia, L. G., Friedman, E. S., Bowden, C. L., & Schoenfeld, D. A. (2014). A novel application of the Intent to Attend assessment to reduce bias due to missing data in a randomized controlled clinical trial. CLINICAL TRIALS, 11(4), 494-502.
  
• Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial. Bobo, W. V., Reilly-Harrington, N. A., Ketter, T. A., Brody, B. D., Kinrys, G., & Kamali, M. (2014). Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial. Journal of affective disorders, 161, 30-35.
  
• Medication adherence in a comparative effectiveness trial for bipolar disorder Sylvia, L. G., Reilly-Harrington, N. A., Leon, A. C., Kansky, C. I., Calabrese, J. R., & Nierenberg, A. A. (2014). Medication adherence in a comparative effectiveness trial for bipolar disorder. ACTA PSYCHIATRICA SCANDINAVICA, 129(5), 359-365.
  
• Update on best practices for managing bipolar depression. Sachs, G. S., & Ketter, T. A. (2014). Update on best practices for managing bipolar depression. journal of clinical psychiatry, 75(5), e413-6.
  
• Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS) Beech, R. D., Leffert, J. J., Lin, A., Sylvia, L. G., Umlauf, S., & Nierenberg, A. (2014). Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS). PHARMACOGENOMICS JOURNAL, 14(2), 182-191.
  
• Blood levels of brain derived neurotrophic factor in women with bipolar disorder and healthy control women Kenna, H. A., Reynolds-May, M., Stepanenko, A., Ketter, T. A., Hallmayer, J., & Rasgon, N. L. (2014). Blood levels of brain derived neurotrophic factor in women with bipolar disorder and healthy control women. JOURNAL OF AFFECTIVE DISORDERS, 156, 214-218.
  
• Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed. Citrome, L., Ketter, T. A., Cucchiaro, J., & Loebel, A. (2014). Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed. Journal of affective disorders, 155, 20-27.
  
• A profile approach to impulsivity in bipolar disorder: the key role of strong emotions Muhtadie, L., Johnson, S. L., Carver, C. S., Gotlib, I. H., & Ketter, T. A. (2014). A profile approach to impulsivity in bipolar disorder: the key role of strong emotions. ACTA PSYCHIATRICA SCANDINAVICA, 129(2), 100-108.
  
• Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): A pragmatic trial of complex treatment for a complex disorder Nierenberg, A. A., Sylvia, L. G., Leon, A. C., Reilly-Harrington, N. A., Shesler, L. W., & Calabrese, J. R. (2014). Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): A pragmatic trial of complex treatment for a complex disorder. CLINICAL TRIALS, 11(1), 114-127.
  
• Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000-2011 Hooshmand, F., Miller, S., Dore, J., Wang, P. W., Hill, S. J., & Ketter, T. A. (2014). Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000-2011. JOURNAL OF AFFECTIVE DISORDERS, 155, 283-287.
  
• Evaluation of reproductive function in women treated for bipolar disorder compared to healthy controls Reynolds-May, M. F., Kenna, H. A., Marsh, W., Stemmle, P. G., Wang, P., & Rasgon, N. L. (2014). Evaluation of reproductive function in women treated for bipolar disorder compared to healthy controls. BIPOLAR DISORDERS, 16(1), 37-47.
  
• Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: Contrasting LiTMUS baseline data with pre-existing placebo controlled trials Friedman, E. S., Calabrese, J. R., Ketter, T. A., Leon, A. C., Thase, M. E., & Reilly-Harrington, N. A. (2014). Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: Contrasting LiTMUS baseline data with pre-existing placebo controlled trials. JOURNAL OF AFFECTIVE DISORDERS, 152, 97-104.
  
• Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire Thai version Waleeprakhon, P., Ittasakul, P., Lotrakul, M., Wisajun, P., Jullagate, S., & Ketter, T. A. (2014). Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire Thai version. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 10, 1497-1502.
  
• General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial Kemp, D. E., Sylvia, L. G., Calabrese, J. R., Nierenberg, A. A., Thase, M. E., & Iosifescu, D. V. (2014). General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial. ACTA PSYCHIATRICA SCANDINAVICA, 129(1), 24-34.
  
• The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders Pacchiarotti, I., Bond, D. J., Baldessarini, R. J., Nolen, W. A., Grunze, H., & Vieta, E. (2013). The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders. AMERICAN JOURNAL OF PSYCHIATRY, 170(11), 1249-1262.
  
• Number needed to treat can be helpful: a response to Alphs et al. Citrome, L., & Ketter, T. A. (2013). Number needed to treat can be helpful: a response to Alphs et al. European neuropsychopharmacology , 23(11), 1656-1657.
  
• Use of Treatment Services in a Comparative Effectiveness Study of Bipolar Disorder Sylvia, L. G., Iosifescu, D., Friedman, E. S., Bernstein, E. E., Bowden, C. L., & Nierenberg, A. A. (2013). Use of Treatment Services in a Comparative Effectiveness Study of Bipolar Disorder. PSYCHIATRIC SERVICES, 64(11), 1119-1126.
  
• Number needed to harm can be clinically useful: a response to Safer and Zito. Citrome, L., & Ketter, T. A. (2013). Number needed to harm can be clinically useful: a response to Safer and Zito. journal of nervous and mental disease, 201(11), 1001-1002.
  
• The Medication Recommendation Tracking Form: A novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness research Reilly-Harrington, N. A., Sylvia, L. G., Leon, A. C., Shesler, L. W., Ketter, T. A., & Nierenberg, A. A. (2013). The Medication Recommendation Tracking Form: A novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness research. JOURNAL OF PSYCHIATRIC RESEARCH, 47(11), 1686-1693.
  
• Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorder Sylvia, L. G., Friedman, E. S., Kocsis, J. H., Bernstein, E. E., Brody, B. D., & Nierenberg, A. A. (2013). Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorder. JOURNAL OF AFFECTIVE DISORDERS, 151(2), 722-727.
  
• Assessing efficacy/effectiveness and safety/tolerability profiles of adjunctive pramipexole in bipolar depression: acute versus long-term data Dell'Osso, B., & Ketter, T. A. (2013). Assessing efficacy/effectiveness and safety/tolerability profiles of adjunctive pramipexole in bipolar depression: acute versus long-term data. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 28(6), 297-304.
  
• First controlled treatment trial of bipolar II hypomania with mixed symptoms: Quetiapine versus placebo Suppes, T., Ketter, T. A., Gwizdowski, I. S., Dennehy, E. B., Hill, S. J., & Cosgrove, V. E. (2013). First controlled treatment trial of bipolar II hypomania with mixed symptoms: Quetiapine versus placebo. JOURNAL OF AFFECTIVE DISORDERS, 150(1), 37-43.
  
• Superior chronic tolerability of adjunctive modafinil compared to pramipexole in treatment-resistant bipolar disorder Dell'Osso, B., Timtim, S., Hooshmand, F., Miller, S., Wang, P. W., & Ketter, T. A. (2013). Superior chronic tolerability of adjunctive modafinil compared to pramipexole in treatment-resistant bipolar disorder. JOURNAL OF AFFECTIVE DISORDERS, 150(1), 130-135.
  
• Long-term aripiprazole effectiveness in bipolar disorder patients decreases with pharmacotherapeutic complexity and degree of baseline mood disturbance Ittasakul, P., Miller, S., Wang, P. W., Hill, S. J., Childers, M. E., & Ketter, T. A. (2013). Long-term aripiprazole effectiveness in bipolar disorder patients decreases with pharmacotherapeutic complexity and degree of baseline mood disturbance. ASIAN BIOMEDICINE, 7(4), 537-544.
  
• Assessing the Roles of Stimulants/Stimulant-like Drugs and Dopamine-agonists in the Treatment of Bipolar Depression Dell'Osso, B., Ketter, T. A., Cremaschi, L., Spagnolin, G., & Altamura, A. C. (2013). Assessing the Roles of Stimulants/Stimulant-like Drugs and Dopamine-agonists in the Treatment of Bipolar Depression. CURRENT PSYCHIATRY REPORTS, 15(8).
  
• Bipolar disorder and attention-deficit/hyperactivity disorder comorbidity in children and adolescents: evidence-based approach to diagnosis and treatment. Miller, S., Chang, K. D., & Ketter, T. A. (2013). Bipolar disorder and attention-deficit/hyperactivity disorder comorbidity in children and adolescents: evidence-based approach to diagnosis and treatment. journal of clinical psychiatry, 74(6), 628-629.
  
• A double-blind, placebo-controlled, multicenter trial of adjunctive armodafinil for the treatment of major depression associated with bipolar I disorder Ketter, T. A., Calabrese, J. R., Yang, R., & Frye, M. A. (2013). A double-blind, placebo-controlled, multicenter trial of adjunctive armodafinil for the treatment of major depression associated with bipolar I disorder. BIPOLAR DISORDERS, 15, 88-88.
  
• Novel Compounds for Acute Management of Bipolar Depression Frye, M. A., Calabrese, J. R., Yang, R., & Ketter, T. (2013). Novel Compounds for Acute Management of Bipolar Depression. BIPOLAR DISORDERS, 15, 13-13.
  
• Efficacy and safety of armodafinil as an adjunctive therapy for the treatment of a major depressive episode associated with bipolar I disorder Frye, M. A., Ketter, T. A., & Yang, R. (2013). Efficacy and safety of armodafinil as an adjunctive therapy for the treatment of a major depressive episode associated with bipolar I disorder. BIPOLAR DISORDERS, 15, 126-127.
  
• Lurasidone treatment for bipolar I depression: effects on quality of life and patient's functioning Ketter, T. A., Cucchiaro, J., Silva, R., Pikalov, A., Sarma, K., & Loebel, A. (2013). Lurasidone treatment for bipolar I depression: effects on quality of life and patient's functioning. BIPOLAR DISORDERS, 15, 91-91.
  
• Use of a novel adjunctive clinical trial design to examine efficacy, safety, and improved generalizability of armodafinil for the treatment of bipolar I depression Calabrese, J. R., Frye, M. A., Yang, R., & Ketter, T. A. (2013). Use of a novel adjunctive clinical trial design to examine efficacy, safety, and improved generalizability of armodafinil for the treatment of bipolar I depression. BIPOLAR DISORDERS, 15, 59-59.
  
• When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed Citrome, L., & Ketter, T. A. (2013). When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 67(5), 407-411.
  
• USE OF A NOVEL ADJUNCTIVE CLINICAL TRIAL DESIGN TO EXAMINE EFFICACY, SAFETY OF ARMODAFINIL FOR THE TREATMENT OF BIPOLAR I DEPRESSION Calabrese, J. R., Ketter, T. A., Yang, R., & Frye, M. A. (2013). USE OF A NOVEL ADJUNCTIVE CLINICAL TRIAL DESIGN TO EXAMINE EFFICACY, SAFETY OF ARMODAFINIL FOR THE TREATMENT OF BIPOLAR I DEPRESSION. VALUE IN HEALTH, 16(3), A51-A52.
  
• A DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL OF ADJUNCTIVE ARMODAFINIL FOR THE TREATMENT OF MAJOR DEPRESSION ASSOCIATED WITH BIPOLAR I DISORDER Frye, M. A., Ketter, T. A., Yang, R., & Calabrese, J. R. (2013). A DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL OF ADJUNCTIVE ARMODAFINIL FOR THE TREATMENT OF MAJOR DEPRESSION ASSOCIATED WITH BIPOLAR I DISORDER. VALUE IN HEALTH, 16(3), A55-A56.
  
• Brain-derived neurotrophic factor val66met genotype and early life stress effects upon bipolar course Miller, S., Hallmayer, J., Wang, P. W., Hill, S. J., Johnson, S. L., & Ketter, T. A. (2013). Brain-derived neurotrophic factor val66met genotype and early life stress effects upon bipolar course. JOURNAL OF PSYCHIATRIC RESEARCH, 47(2), 252-258.
  
• PILOT RANDOMIZED TRIAL OF A CROSS-DIAGNOSIS COLLABORATIVE CARE PROGRAM FOR PATIENTS WITH MOOD DISORDERS Kilbourne, A. M., Li, D., Lai, Z., Waxmonsky, J., & Ketter, T. (2013). PILOT RANDOMIZED TRIAL OF A CROSS-DIAGNOSIS COLLABORATIVE CARE PROGRAM FOR PATIENTS WITH MOOD DISORDERS. DEPRESSION AND ANXIETY, 30(2), 116-122.
  
• Use of adjunctive stimulants in adult bipolar depression Dell'Osso, B., & Ketter, T. A. (2013). Use of adjunctive stimulants in adult bipolar depression. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 16(1), 55-68.
  
• Lithium Treatment Moderate-Dose Use Study (LiTMUS) for Bipolar Disorder: A Randomized Comparative Effectiveness Trial of Optimized Personalized Treatment With and Without Lithium Nierenberg, A. A., Friedman, E. S., Bowden, C. L., Sylvia, L. G., Thase, M. E., & Calabrese, J. R. (2013). Lithium Treatment Moderate-Dose Use Study (LiTMUS) for Bipolar Disorder: A Randomized Comparative Effectiveness Trial of Optimized Personalized Treatment With and Without Lithium. AMERICAN JOURNAL OF PSYCHIATRY, 170(1), 102-110.
  
• Enhanced Ziprasidone Combination Therapy Effectiveness in Obese Compared to Nonobese Patients With Bipolar Disorder Miller, S., Ittasakul, P., Wang, P. W., Hill, S. J., Childers, M. E., & Ketter, T. A. (2012). Enhanced Ziprasidone Combination Therapy Effectiveness in Obese Compared to Nonobese Patients With Bipolar Disorder. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 32(6), 814-819.
  
• Addressing challenges in bipolar diagnosis: what do good clinicians already do? An editorial comment to Phelps J, Ghaemi SN 'The mistaken claim of bipolar 'overdiagnosis': solving the false positives problem for DSM-5/ICD-11'. Ketter, T. A., & Citrome, L. (2012). Addressing challenges in bipolar diagnosis: what do good clinicians already do? An editorial comment to Phelps J, Ghaemi SN 'The mistaken claim of bipolar 'overdiagnosis': solving the false positives problem for DSM-5/ICD-11'. Acta psychiatrica Scandinavica, 126(6), 393-394.
  
• Torticollis after low-dose aripiprazole administration in a Thai schizophrenia patient. Ittasakul, P., Srivastava, S., Hiranyatheb, T., & Ketter, T. A. (2012). Torticollis after low-dose aripiprazole administration in a Thai schizophrenia patient. Asian journal of psychiatry, 5(4), 365-366.
  
• Effectiveness of quetiapine plus lamotrigine maintenance therapy in challenging bipolar disorder patients Ittasakul, P., Johnson, K., Srivastava, S., Childers, M., Brook, J., & Ketter, T. (2012). Effectiveness of quetiapine plus lamotrigine maintenance therapy in challenging bipolar disorder patients. ASIA-PACIFIC PSYCHIATRY, 4, 117-118.
  
• Progression of female reproductive stages associated with bipolar illness exacerbation Marsh, W. K., Ketter, T. A., Crawford, S. L., Johnson, J. V., Kroll-Desrosiers, A. R., & Rothschild, A. J. (2012). Progression of female reproductive stages associated with bipolar illness exacerbation. BIPOLAR DISORDERS, 14(5), 515-526.
  
• Pilot study of the efficacy of double-blind, placebo-controlled one-week olanzapine stabilization therapy in heterogeneous symptomatic bipolar disorder patients Srivastava, S., Wang, P. W., Hill, S. J., Childers, M. E., Keller, K. L., & Ketter, T. A. (2012). Pilot study of the efficacy of double-blind, placebo-controlled one-week olanzapine stabilization therapy in heterogeneous symptomatic bipolar disorder patients. JOURNAL OF PSYCHIATRIC RESEARCH, 46(7), 920-926.
  
• Effectiveness of quetiapine plus lamotrigine maintenance therapy in challenging bipolar disorder patients Ittasakul, P., Johnson, K. R., Srivastava, S., Childers, M. E., Brooks, J. O., & Ketter, T. A. (2012). Effectiveness of quetiapine plus lamotrigine maintenance therapy in challenging bipolar disorder patients. JOURNAL OF AFFECTIVE DISORDERS, 137(1-3), 139-145.
  
• Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392) Carlson, B. X., Ketter, T. A., Sun, W., Timko, K., McQuade, R. D., & Marcus, R. (2012). Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392). BIPOLAR DISORDERS, 14(1), 41-53.
  
• Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorder Sylvia, L. G., Reilly-Harrington, N. A., Leon, A. C., Kansky, C. I., Ketter, T. A., & Nierenberg, A. A. (2012). Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorder. CLINICAL TRIALS, 9(1), 94-101.
  
• Aims and Results of the NIMH Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) Bowden, C. L., Perlis, R. H., Thase, M. E., Ketter, T. A., Ostacher, M. M., & Sachs, G. S. (2012). Aims and Results of the NIMH Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). CNS NEUROSCIENCE & THERAPEUTICS, 18(3), 243-249.
  
• Clinical Relevance of Treatments for Acute Bipolar Disorder: Balancing Therapeutic and Adverse Effects Srivastava, S., & Ketter, T. A. (2011). Clinical Relevance of Treatments for Acute Bipolar Disorder: Balancing Therapeutic and Adverse Effects. CLINICAL THERAPEUTICS, 33(12), B40-B48.
  
• Sleep matters: Sleep functioning and course of illness in bipolar disorder Gruber, J., Miklowitz, D. J., Harvey, A. G., Frank, E., Kupfer, D., & Ketter, T. A. (2011). Sleep matters: Sleep functioning and course of illness in bipolar disorder. JOURNAL OF AFFECTIVE DISORDERS, 134(1-3), 416-420.
  
• Gender-specific lipid profiles in patients with bipolar disorder Vemuri, M., Kenna, H. A., Wang, P. W., Ketter, T. A., & Rasgon, N. L. (2011). Gender-specific lipid profiles in patients with bipolar disorder. JOURNAL OF PSYCHIATRIC RESEARCH, 45(8), 1036-1041.
  
• Open adjunctive ziprasidone associated with weight loss in obese and overweight bipolar disorder patients Wang, P. W., Hill, S. J., Childers, M. E., Chandler, R. A., Rasgon, N. L., & Ketter, T. A. (2011). Open adjunctive ziprasidone associated with weight loss in obese and overweight bipolar disorder patients. JOURNAL OF PSYCHIATRIC RESEARCH, 45(8), 1128-1132.
  
• Strategies for the early recognition of bipolar disorder. Ketter, T. A. (2011). Strategies for the early recognition of bipolar disorder. journal of clinical psychiatry, 72(7).
  
• DSM-5 mixed features specifier may increase complexity without enhancing milder mixed symptom detection in bipolar disorder patients: a 36 case series Ketter, T. A., Srivastava, S., Wang, P. W., Childers, M. E., Hill, S. J., & Keller, K. L. (2011). DSM-5 mixed features specifier may increase complexity without enhancing milder mixed symptom detection in bipolar disorder patients: a 36 case series. BIPOLAR DISORDERS, 13, 62-62.
  
• Pilot study of the effectiveness of double-blind, placebo-controlled brief olanzapine therapy in heterogeneous symptomatic bipolar disorder patients Srivastava, S., Wang, P. W., Childers, M. E., Hill, S. J., Keller, K. L., & Ketter, T. A. (2011). Pilot study of the effectiveness of double-blind, placebo-controlled brief olanzapine therapy in heterogeneous symptomatic bipolar disorder patients. BIPOLAR DISORDERS, 13, 93-94.
  
• Effectiveness of Aripiprazole in Bipolar Disorder Patients Primarily Taking Complex Pharmacotherapy Ittasakul, P., Srivastava, S., Wang, P. W., Hill, S. J., Childers, M. E., & Ketter, T. A. (2011). Effectiveness of Aripiprazole in Bipolar Disorder Patients Primarily Taking Complex Pharmacotherapy. BIOLOGICAL PSYCHIATRY, 69(9), 92S-92S.
  
• Treatments for bipolar disorder: can number needed to treat/harm help inform clinical decisions? Ketter, T. A., Citrome, L., Wang, P. W., Culver, J. L., & Srivastava, S. (2011). Treatments for bipolar disorder: can number needed to treat/harm help inform clinical decisions?. ACTA PSYCHIATRICA SCANDINAVICA, 123(3), 175-189.
  
• Lamotrigine plus quetiapine combination therapy in treatment-resistant bipolar depression Ahn, Y. M., Nam, J. Y., Culver, J. L., Marsh, W. K., Bonner, J. C., & Ketter, T. A. (2011). Lamotrigine plus quetiapine combination therapy in treatment-resistant bipolar depression. ANNALS OF CLINICAL PSYCHIATRY, 23(1), 17-24.
  
• Early symptom change and prediction of subsequent remission with olanzapine augmentation in divalproex-resistant bipolar mixed episodes Houston, J. P., Ketter, T. A., Case, M., Bowden, C., Degenhardt, E. K., & Tohen, M. (2011). Early symptom change and prediction of subsequent remission with olanzapine augmentation in divalproex-resistant bipolar mixed episodes. JOURNAL OF PSYCHIATRIC RESEARCH, 45(2), 169-173.
  
• Safety and Tolerability Associated With Second-Generation Antipsychotic Polytherapy in Bipolar Disorder: Findings From the Systematic Treatment Enhancement Program for Bipolar Disorder Brooks, J. O., Goldberg, J. F., Ketter, T. A., Miklowitz, D. J., Calabrese, J. R., & Thase, M. E. (2011). Safety and Tolerability Associated With Second-Generation Antipsychotic Polytherapy in Bipolar Disorder: Findings From the Systematic Treatment Enhancement Program for Bipolar Disorder. JOURNAL OF CLINICAL PSYCHIATRY, 72(2), 240-247.
  
• Prefrontal and paralimbic metabolic dysregulation related to sustained attention in euthymic older adults with bipolar disorder Brooks, J. O., Bearden, C. E., Hoblyn, J. C., Woodard, S. A., & Ketter, T. A. (2010). Prefrontal and paralimbic metabolic dysregulation related to sustained attention in euthymic older adults with bipolar disorder. BIPOLAR DISORDERS, 12(8), 866-874.
  
• In search of optimal lithium levels and olanzapine doses in the long-term treatment of bipolar I disorder. A post-hoc analysis of the maintenance study by Tohen et al. 2005 Severus, W. E., Lipkovich, I. A., Licht, R. W., Young, A. H., Greil, W., & Tohen, M. (2010). In search of optimal lithium levels and olanzapine doses in the long-term treatment of bipolar I disorder. A post-hoc analysis of the maintenance study by Tohen et al. 2005. EUROPEAN PSYCHIATRY, 25(8), 443-449.
  
• The Link Between Bipolar Disorders and Creativity: Evidence from Personality and Temperament Studies Srivastava, S., & Ketter, T. A. (2010). The Link Between Bipolar Disorders and Creativity: Evidence from Personality and Temperament Studies. CURRENT PSYCHIATRY REPORTS, 12(6), 522-530.
  
• What Have We Learned about Trial Design From NIMH-Funded Pragmatic Trials? March, J., Kraemer, H. C., Trivedi, M., Csernansky, J., Davis, J., & Glick, I. D. (2010). What Have We Learned about Trial Design From NIMH-Funded Pragmatic Trials?. NEUROPSYCHOPHARMACOLOGY, 35(13), 2491-2501.
  
• Long-term effectiveness of quetiapine in bipolar disorder in a clinical setting Ketter, T. A., Brooks, J. O., Hoblyn, J. C., Holland, A. A., Nam, J. Y., & Bonner, J. C. (2010). Long-term effectiveness of quetiapine in bipolar disorder in a clinical setting. JOURNAL OF PSYCHIATRIC RESEARCH, 44(14), 921-929.
  
• Higher prevalence of bipolar I disorder among Asian and Latino compared to Caucasian patients receiving treatment Hwang, S. Hj., Childers, M. E., Wang, P. W., Nam, J. Y., Keller, K. L., & Ketter, T. A. (2010). Higher prevalence of bipolar I disorder among Asian and Latino compared to Caucasian patients receiving treatment. ASIA-PACIFIC PSYCHIATRY, 2(3), 156-165.
  
• Nosology, diagnostic challenges, and unmet needs in managing bipolar disorder. Ketter, T. A. (2010). Nosology, diagnostic challenges, and unmet needs in managing bipolar disorder. journal of clinical psychiatry, 71(10).
  
• Adjunctive Armodafinil for Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Proof-of-Concept Study Calabrese, J. R., Ketter, T. A., Youakim, J. M., Tiller, J. M., Yang, R., & Frye, M. A. (2010). Adjunctive Armodafinil for Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Proof-of-Concept Study. JOURNAL OF CLINICAL PSYCHIATRY, 71(10), 1363-1370.
  
• Toward interaction of affective and cognitive contributors to creativity in bipolar disorders: A controlled study Srivastava, S., Childers, M. E., Baek, J. H., Strong, C. M., Hill, S. J., & Ketter, T. A. (2010). Toward interaction of affective and cognitive contributors to creativity in bipolar disorders: A controlled study. JOURNAL OF AFFECTIVE DISORDERS, 125(1-3), 27-34.
  
• Metabolic dysfunction in women with bipolar disorder: the potential influence of family history of type 2 diabetes mellitus Rasgon, N. L., Kenna, H. A., Reynolds-May, M. F., Stemmle, P. G., Vemuri, M., & Ketter, T. A. (2010). Metabolic dysfunction in women with bipolar disorder: the potential influence of family history of type 2 diabetes mellitus. BIPOLAR DISORDERS, 12(5), 504-513.
  
• Divalproex extended-release in acute bipolar II depression Wang, P. W., Nowakowska, C., Chandler, R. A., Hill, S. J., Nam, J. Y., & Ketter, T. A. (2010). Divalproex extended-release in acute bipolar II depression. JOURNAL OF AFFECTIVE DISORDERS, 124(1-2), 170-173.
  
• Diagnostic features, prevalence, and impact of bipolar disorder. Ketter, T. A. (2010). Diagnostic features, prevalence, and impact of bipolar disorder. journal of clinical psychiatry, 71(6).
  
• Metabolic evidence of corticolimbic dysregulation in bipolar mania Brooks, J. O., Hoblyn, J. C., & Ketter, T. A. (2010). Metabolic evidence of corticolimbic dysregulation in bipolar mania. PSYCHIATRY RESEARCH-NEUROIMAGING, 181(2), 136-140.
  
• Strategies for monitoring outcomes in patients with bipolar disorder. Ketter, T. A. (2010). Strategies for monitoring outcomes in patients with bipolar disorder. Primary care companion to the Journal of clinical psychiatry, 12, 10-16.
  
• Linkage Disequilibrium Mapping of The Chromosome 6q21-22.31 Bipolar I Disorder Susceptibility Locus Fan, J., Ionita-Laza, I., McQueen, M. B., Devlin, B., Purcell, S., & Smoller, J. W. (2010). Linkage Disequilibrium Mapping of The Chromosome 6q21-22.31 Bipolar I Disorder Susceptibility Locus. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 153B(1), 29-37.
  
• Atypical Antipsychotics for Acute Manic and Mixed Episodes in Children and Adolescents with Bipolar Disorder Efficacy and Tolerability Singh, M. K., Ketter, T. A., & Chang, K. D. (2010). Atypical Antipsychotics for Acute Manic and Mixed Episodes in Children and Adolescents with Bipolar Disorder Efficacy and Tolerability. DRUGS, 70(4), 433-442.
  
• Rapid antipsychotic response with ziprasidone predicts subsequent acute manic/mixed episode remission Ketter, T. A., Agid, O., Kapur, S., Loebel, A., Siu, C. O., & Romano, S. J. (2010). Rapid antipsychotic response with ziprasidone predicts subsequent acute manic/mixed episode remission. JOURNAL OF PSYCHIATRIC RESEARCH, 44(1), 8-14.
  
• Resting Prefrontal Hypometabolism and Paralimbic Hypermetabolism Related to Verbal Recall Deficits in Euthymic Older Adults With Bipolar Disorder Brooks, J. O., Rosen, A. C., Hoblyn, J. C., Woodard, S. A., Krasnykh, O., & Ketter, T. A. (2009). Resting Prefrontal Hypometabolism and Paralimbic Hypermetabolism Related to Verbal Recall Deficits in Euthymic Older Adults With Bipolar Disorder. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 17(12), 1022-1029.
  
• Lithium treatment-moderate dose use study (LiTMUS) for bipolar disorder: rationale and design Nierenberg, A. A., Sylvia, L. G., Leon, A. C., Reilly-Harrington, N. A., Ketter, T. A., & Iosifescu, D. V. (2009). Lithium treatment-moderate dose use study (LiTMUS) for bipolar disorder: rationale and design. CLINICAL TRIALS, 6(6), 637-648.
  
• Olanzapine-Divalproex Combination Versus Divalproex Monotherapy in the Treatment of Bipolar Mixed Episodes: A Double-Blind, Placebo-Controlled Study Houston, J. P., Tohen, M., Degenhardt, E. K., Jamal, H. H., Liu, L. Ll., & Ketter, T. A. (2009). Olanzapine-Divalproex Combination Versus Divalproex Monotherapy in the Treatment of Bipolar Mixed Episodes: A Double-Blind, Placebo-Controlled Study. JOURNAL OF CLINICAL PSYCHIATRY, 70(11), 1540-1547.
  
• Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia Mansour, H. A., Talkowski, M. E., Wood, J., Chowdari, Kv., McClain, L., & Nimgaonkar, V. L. (2009). Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. BIPOLAR DISORDERS, 11(7), 701-710.
  
• Teaching the philosophy and tools of evidence-based medicine: misunderstandings and solutions. Citrome, L., & Ketter, T. A. (2009). Teaching the philosophy and tools of evidence-based medicine: misunderstandings and solutions. Journal of evidence-based medicine, 2(4), 220-225.
  
• Mood Stabilization and Destabilization During Acute and Continuation Phase Treatment for Bipolar I Disorder With Lamotrigine or Placebo Goldberg, J. F., Calabrese, J. R., Saville, B. R., Frye, M. A., Ketter, T. A., & Goodwin, F. K. (2009). Mood Stabilization and Destabilization During Acute and Continuation Phase Treatment for Bipolar I Disorder With Lamotrigine or Placebo. JOURNAL OF CLINICAL PSYCHIATRY, 70(9), 1273-1280.
  
• Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies Frye, M. A., Yatham, L., Ketter, T. A., Goldberg, J., Suppes, T., & Adams, B. (2009). Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies. ACTA PSYCHIATRICA SCANDINAVICA, 120(1), 10-13.
  
• Dorsolateral and dorsomedial prefrontal gray matter density changes associated with bipolar depression Brooks, J. O., Bonner, J. C., Rosen, A. C., Wang, P. W., Hoblyn, J. C., & Ketter, T. A. (2009). Dorsolateral and dorsomedial prefrontal gray matter density changes associated with bipolar depression. PSYCHIATRY RESEARCH-NEUROIMAGING, 172(3), 200-204.
  
• Adjunctive armodafinil for major depression associated with bipolar I disorder: a randomized, double-blind, placebo-controlled study Calabrese, J. R., Ketter, T. A., Youakim, J. M., Tiller, J., Yang, R., & Frye, M. A. (2009). Adjunctive armodafinil for major depression associated with bipolar I disorder: a randomized, double-blind, placebo-controlled study. BIPOLAR DISORDERS, 11, 26-26.
  
• The long term effectiveness of quetiapine plus lamotrigine therapy in bipolar patients Ketter, T. A., Johnson, K., Childers, M., Srivastava, S., Brooks, J. O., & Hoblyn, J. C. (2009). The long term effectiveness of quetiapine plus lamotrigine therapy in bipolar patients. BIPOLAR DISORDERS, 11, 53-53.
  
• Do positive emotions predict symptomatic change in bipolar disorder? Gruber, J., Culver, J. L., Johnson, S. L., Nam, J. Y., Keller, K. L., & Ketter, T. A. (2009). Do positive emotions predict symptomatic change in bipolar disorder?. BIPOLAR DISORDERS, 11(3), 330-336.
  
• Increased depressive symptoms in menopausal age women with bipolar disorder: Age and gender comparison Marsh, W. K., Ketter, T. A., & Rasgon, N. L. (2009). Increased depressive symptoms in menopausal age women with bipolar disorder: Age and gender comparison. JOURNAL OF PSYCHIATRIC RESEARCH, 43(8), 798-802.
  
• A Double-Blind, Placebo-Controlled Trial of Olanzapine Augmentation in Bipolar I Disorder, Mixed Episode Houston, J. P., Tohen, M., Degenhardt, E., Jamal, H. H., Liu, L., & Ketter, T. A. (2009). A Double-Blind, Placebo-Controlled Trial of Olanzapine Augmentation in Bipolar I Disorder, Mixed Episode. BIOLOGICAL PSYCHIATRY, 65(8), 131S-131S.
  
• Sleep functioning in relation to mood, function, and quality of life at entry to the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) Gruber, J., Harvey, A. G., Wang, P. W., Brooks, J. O., Thase, M. E., & Ketter, T. A. (2009). Sleep functioning in relation to mood, function, and quality of life at entry to the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). JOURNAL OF AFFECTIVE DISORDERS, 114(1-3), 41-49.
  
• Teaching the philosophy and tools of evidence-based medicine: misunderstandings and solutions Citrome, L., & Ketter, T. A. (2009). Teaching the philosophy and tools of evidence-based medicine: misunderstandings and solutions. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 63(3), 353-359.
  
• Corticolimbic metabolic dysregulation in euthymic older adults with bipolar disorder Brooks, J. O., Hoblyn, J. C., Woodard, S. A., Rosen, A. C., & Ketter, T. A. (2009). Corticolimbic metabolic dysregulation in euthymic older adults with bipolar disorder. JOURNAL OF PSYCHIATRIC RESEARCH, 43(5), 497-502.
  
• Treating bipolar disorder: monotherapy versus combination therapy. Ketter, T. A. (2009). Treating bipolar disorder: monotherapy versus combination therapy. journal of clinical psychiatry, 70(2).
  
• Depressive Illness Burden Associated With Complex Polypharmacy in Patients With Bipolar Disorder: Findings From the STEP-BD Goldberg, J. F., Brooks, J. O., Kurita, K., Hoblyn, J. C., Ghaemi, N., & Thase, M. E. (2009). Depressive Illness Burden Associated With Complex Polypharmacy in Patients With Bipolar Disorder: Findings From the STEP-BD. JOURNAL OF CLINICAL PSYCHIATRY, 70(2), 155-162.
  
• Decreased prefrontal, anterior cingulate, insula, and ventral striatal metabolism in medication-free depressed outpatients with bipolar disorder. Brooks, J. O., Wang, P. W., Bonner, J. C., Rosen, A. C., Hoblyn, J. C., & Ketter, T. A. (2009). Decreased prefrontal, anterior cingulate, insula, and ventral striatal metabolism in medication-free depressed outpatients with bipolar disorder. Journal of psychiatric research, 43(3), 181-188.
  
• Insulin resistance and hyperlipidemia in women with bipolar disorder. Stemmle, P. G., Kenna, H. A., Wang, P. W., Hill, S. J., Ketter, T. A., & Rasgon, N. L. (2009). Insulin resistance and hyperlipidemia in women with bipolar disorder. Journal of psychiatric research, 43(3), 341-343.
  
• Combination therapy versus monotherapy in bipolar disorder. Ketter, T. A. (2008). Combination therapy versus monotherapy in bipolar disorder. journal of clinical psychiatry, 69(12).
  
• Effectiveness of lamotrigine in bipolar disorder in a clinical setting Ketter, T. A., Brooks, J. O., Hoblyn, J. C., Champion, L. M., Nam, J. Y., & Bonner, J. C. (2008). Effectiveness of lamotrigine in bipolar disorder in a clinical setting. JOURNAL OF PSYCHIATRIC RESEARCH, 43(1), 13-23.
  
• Interregional cerebral metabolic associativity during a continuous performance task (Part II) : Differential alterations in bipolar and unipolar disorders Benson, B. E., Willis, M. W., Ketter, T. A., Speer, A., Kimbrell, T. A., & Post, R. M. (2008). Interregional cerebral metabolic associativity during a continuous performance task (Part II) : Differential alterations in bipolar and unipolar disorders. PSYCHIATRY RESEARCH-NEUROIMAGING, 164(1), 30-47.
  
• Interregional cerebral metabolic associativity during a continuous performance task (Part I): Healthy adults Willis, M. W., Benson, B. E., Ketter, T. A., Kimbrell, T. A., George, M. S., & Post, R. M. (2008). Interregional cerebral metabolic associativity during a continuous performance task (Part I): Healthy adults. PSYCHIATRY RESEARCH-NEUROIMAGING, 164(1), 16-29.
  
• A new US-UK diagnostic project: mood elevation and depression in first-year undergraduates at Oxford and Stanford universities Chandler, R. A., Wang, P. W., Ketter, T. A., & Goodwin, G. M. (2008). A new US-UK diagnostic project: mood elevation and depression in first-year undergraduates at Oxford and Stanford universities. ACTA PSYCHIATRICA SCANDINAVICA, 118(1), 81-85.
  
• Incorporating trial data into bipolar disorder management. Ketter, T. A. (2008). Incorporating trial data into bipolar disorder management. journal of clinical psychiatry, 69(7).
  
• Caregiver burden and health in bipolar disorder - A cluster analytic approach Perlick, D. A., Rosenheck, R. A., Miklowitz, D. J., Kaczynski, R., Link, B., & Sachs, G. (2008). Caregiver burden and health in bipolar disorder - A cluster analytic approach. JOURNAL OF NERVOUS AND MENTAL DISEASE, 196(6), 484-491.
  
• Adjunctive zonisamide for weight loss in euthymic bipolar disorder patients: A pilot study Wang, P. W., Yang, Y.- shou, Chandler, R. A., Nowakowska, C., Alarcon, A. M., & Ketter, T. A. (2008). Adjunctive zonisamide for weight loss in euthymic bipolar disorder patients: A pilot study. JOURNAL OF PSYCHIATRIC RESEARCH, 42(6), 451-457.
  
• Insulin resistance and hyperlipidemia in women with bipolar disorder Rasgon, N. L., Stemmle, P. G., Kenna, H. A., Wong, P. W., Hill, S. J., & Ketter, T. A. (2008). Insulin resistance and hyperlipidemia in women with bipolar disorder. EUROPEAN PSYCHIATRY, 23, S235-S235.
  
• Increased frequency of depressive episodes during the menopausal transition in women with bipolar disorder: Preliminary report Marsh, W. K., Templeton, A., Ketter, T. A., & Rasgon, N. L. (2008). Increased frequency of depressive episodes during the menopausal transition in women with bipolar disorder: Preliminary report. JOURNAL OF PSYCHIATRIC RESEARCH, 42(3), 247-251.
  
• Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder Konarski, J. Z., McIntyre, R. S., Kennedy, S. H., Rafi-Tari, S., Soczynska, J. K., & Ketter, T. A. (2008). Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder. BIPOLAR DISORDERS, 10(1), 1-37.
  
• Monotherapy Versus Combined Treatment With Second-Generation Antipsychotics in Bipolar Disorder Ketter, T. A. (2008). Monotherapy Versus Combined Treatment With Second-Generation Antipsychotics in Bipolar Disorder. JOURNAL OF CLINICAL PSYCHIATRY, 69, 9-15.
  
• Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder Goldberg, J. F., Bowden, C. L., Calabrese, J. R., Ketter, T. A., Dann, R. S., & Post, R. M. (2008). Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder. BIOLOGICAL PSYCHIATRY, 63(1), 125-130.
  
• Decreased prefrontal, anterior cingulate, insula, and ventral striatal metabolism in medication-free depressed outpatients with bipolar disorder Brooks, J. O., Wang, P. W., Bonner, J. C., Rosen, A. C., Hoblyn, J. C., & Ketter, T. A. (2008). Decreased prefrontal, anterior cingulate, insula, and ventral striatal metabolism in medication-free depressed outpatients with bipolar disorder. JOURNAL OF PSYCHIATRIC RESEARCH, 43(3), 181-188.
  
• Insulin resistance and hyperlipidemia in women with bipolar disorder Stemmle, P. G., Kenna, H. A., Wang, P. W., Hill, S. J., Ketter, T. A., & Rasgon, N. L. (2008). Insulin resistance and hyperlipidemia in women with bipolar disorder. JOURNAL OF PSYCHIATRIC RESEARCH, 43(3), 341-343.
  
• Switching from Other Agents to Extended-Release Carbamazepine in Acute Mania El-Mallakh, R. S., Ketter, T. A., Weisler, R. H., Hirschfeld, R., Cutler, A. J., & Kalali, A. H. (2008). Switching from Other Agents to Extended-Release Carbamazepine in Acute Mania. PSYCHOPHARMACOLOGY BULLETIN, 41(1), 52-58.
  
• Enhanced creativity in bipolar disorder patients: A controlled study Santosa, C. A., Strong, C. M., Nowakowska, C., Wang, P. W., Rennicke, C. M., & Ketter, T. A. (2007). Enhanced creativity in bipolar disorder patients: A controlled study. JOURNAL OF AFFECTIVE DISORDERS, 100(1-3), 31-39.
  
• Is a lack of disgust something to fear? A functional magnetic resonance imaging facial emotion recognition study in euthymic bipolar disorder patients Malhi, G. S., Lagopoulos, J., Sachdev, P. S., Ivanovski, B., Shnier, R., & Ketter, T. (2007). Is a lack of disgust something to fear? A functional magnetic resonance imaging facial emotion recognition study in euthymic bipolar disorder patients. BIPOLAR DISORDERS, 9(4), 345-357.
  
• Temperament-creativity relationships in mood disorder patients, healthy controls and highly creative individuals Strong, C. M., Nowakowska, C., Santosa, C. M., Wang, P. W., Kraemer, H. C., & Ketter, T. A. (2007). Temperament-creativity relationships in mood disorder patients, healthy controls and highly creative individuals. JOURNAL OF AFFECTIVE DISORDERS, 100(1-3), 41-48.
  
• Effectiveness of adjunctive antidepressant treatment for bipolar depression Sachs, G. S., Nierenberg, A. A., Calabrese, J. R., Marangell, L. B., Wisniewski, S. R., & Thase, M. E. (2007). Effectiveness of adjunctive antidepressant treatment for bipolar depression. NEW ENGLAND JOURNAL OF MEDICINE, 356(17), 1711-1722.
  
• Regional cerebral gray matter density changes associated with creativity in healthy volunteers Bonner, J. C., Ketter, T. A., Wang, P. W., Garcia-Amador, M., & Brooks, J. O. (2007). Regional cerebral gray matter density changes associated with creativity in healthy volunteers. BIOLOGICAL PSYCHIATRY, 61(8), 113S-114S.
  
• Relations between delayed memory and cerebral metabolism in older euthymic adults with bipolar disorder Brooks, J. O., Hoblyn, J. C., Woodard, S., Rosen, A. C., Krasnykh, O., & Schatzberg, A. F. (2007). Relations between delayed memory and cerebral metabolism in older euthymic adults with bipolar disorder. BIOLOGICAL PSYCHIATRY, 61(8), 114S-114S.
  
• Safety and efficacy of anticonvulsants in elderly patients with psychiatric disorders: oxcarbazepine, topiramate and gabapentin Sommer, B. R., Fenn, H. H., & Ketter, T. A. (2007). Safety and efficacy of anticonvulsants in elderly patients with psychiatric disorders: oxcarbazepine, topiramate and gabapentin. EXPERT OPINION ON DRUG SAFETY, 6(2), 133-145.
  
• Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-controlled study Cookson, J., Keck, P. E., Ketterc, T. A., & Macfadden, W. (2007). Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-controlled study. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 22(2), 93-100.
  
• Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania Ketter, T. A., Jones, M., & Paulsson, B. (2007). Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania. JOURNAL OF AFFECTIVE DISORDERS, 100, S45-S53.
  
• Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness - Principles and practice Post, R. M., Ketter, T. A., Uhde, T., & Ballenger, J. C. (2007). Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness - Principles and practice. CNS DRUGS, 21(1), 47-71.
  
• Bipolar disorder: Improving diagnosis and optimizing integrated care Culver, J. L., Arnow, B. A., & Ketter, T. A. (2007). Bipolar disorder: Improving diagnosis and optimizing integrated care. JOURNAL OF CLINICAL PSYCHOLOGY, 63(1), 73-92.
  
• Introduction - Advancing understanding of the effectiveness of quetiapine in acute mania Ketter, T. A. (2007). Introduction - Advancing understanding of the effectiveness of quetiapine in acute mania. JOURNAL OF AFFECTIVE DISORDERS, 100, S1-S3.
  
• Perceptions of weight gain and bipolar pharmacotherapy: results of a 2005 survey of physicians in clinical practice Ketter, T. A., & Haupt, D. W. (2006). Perceptions of weight gain and bipolar pharmacotherapy: results of a 2005 survey of physicians in clinical practice. CURRENT MEDICAL RESEARCH AND OPINION, 22(12), 2345-2353.
  
• Effectiveness of quetiapine in a clinical setting Ketter, T. A., Holland, A. A., Nam, J. Y., Culver, J. L., Wang, P. W., & Bonner, J. C. (2006). Effectiveness of quetiapine in a clinical setting. NEUROPSYCHOPHARMACOLOGY, 31, S234-S234.
  
• Overweight and obesity in bipolar disorders Wang, P. W., Sachs, G. S., Zarate, C. A., Marangell, L. B., Calabrese, J. R., & Ketter, T. A. (2006). Overweight and obesity in bipolar disorders. JOURNAL OF PSYCHIATRIC RESEARCH, 40(8), 762-764.
  
• Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: An evaluation of 2 placebo-controlled maintenance trials Frye, M. A., Yatham, L. N., Calabrese, J. R., Bowden, C. L., Ketter, T. A., & Thompson, T. R. (2006). Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: An evaluation of 2 placebo-controlled maintenance trials. JOURNAL OF CLINICAL PSYCHIATRY, 67(11), 1721-1728.
  
• Omega-3 fatty acids in bipolar disorder: Clinical and research considerations Marangell, L. B., Suppes, T., Ketter, T. A., Dennehy, E. B., Zboyan, H., & Sachs, G. (2006). Omega-3 fatty acids in bipolar disorder: Clinical and research considerations. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 75(4-5), 315-321.
  
• The use of antiepileptic drugs in bipolar disorders. A review based on evidence from controlled trials Weisler, R. H., Cutler, A. J., Ballenger, J. C., Post, R. M., & Ketter, T. A. (2006). The use of antiepileptic drugs in bipolar disorders. A review based on evidence from controlled trials. CNS SPECTRUMS, 11(10), 788-799.
  
• Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature Nasrallah, H. A., Ketter, T. A., & Kalali, A. H. (2006). Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature. JOURNAL OF AFFECTIVE DISORDERS, 95(1-3), 69-78.
  
• Adjunctive aripiprazole in treatment-resistant bipolar depression. Ketter, T. A., Wang, P. W., Chandler, R. A., Culver, J. L., & Alarcon, A. M. (2006). Adjunctive aripiprazole in treatment-resistant bipolar depression. Annals of clinical psychiatry , 18(3), 169-172.
  
• Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder Bowden, C. L., Calabrese, J. R., Ketter, T. A., Sachs, G. S., White, R. L., & Thompson, T. R. (2006). Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder. AMERICAN JOURNAL OF PSYCHIATRY, 163(7), 1199-1201.
  
• Preliminary evidence of differential relations between prefrontal cortex metabolism and sustained attention in depressed adults with bipolar disorder and healthy controls Brooks, J. O., Wang, P. W., Strong, C., Sachs, N., Hoblyn, J. C., & Ketter, T. A. (2006). Preliminary evidence of differential relations between prefrontal cortex metabolism and sustained attention in depressed adults with bipolar disorder and healthy controls. BIPOLAR DISORDERS, 8(3), 248-254.
  
• Recurrence in bipolar I disorder: A post hoc analysis excluding relapses in two double-blind maintenance studies Calabrese, J. R., Goldberg, J. F., Ketter, T. A., Suppes, T., Frye, M., & Thompson, T. R. (2006). Recurrence in bipolar I disorder: A post hoc analysis excluding relapses in two double-blind maintenance studies. BIOLOGICAL PSYCHIATRY, 59(11), 1061-1064.
  
• Safety and tolerability of mood-stabilising anticonvulsants in the elderly Fenn, H. H., Sommer, B. R., Ketter, T. A., & Alldredge, B. (2006). Safety and tolerability of mood-stabilising anticonvulsants in the elderly. EXPERT OPINION ON DRUG SAFETY, 5(3), 401-416.
  
• Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder Sachs, G., Bowden, C., Calabrese, J. R., Ketter, T., Thompson, T., & Bentley, B. (2006). Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder. BIPOLAR DISORDERS, 8(2), 175-181.
  
• Magnetic resonance spectroscopic measurement of cerebral gamma-aminobutyric acid concentrations in patients with bipolar disorders Wang, P. W., Sailasuta, N., Chandler, R. A., & Ketter, T. A. (2006). Magnetic resonance spectroscopic measurement of cerebral gamma-aminobutyric acid concentrations in patients with bipolar disorders. ACTA NEUROPSYCHIATRICA, 18(2), 120-126.
  
• The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: A randomized trial Ketter, T. A., Greist, J. H., Graham, J. A., Roberts, J. N., Thompson, T. R., & Nanry, K. P. (2006). The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: A randomized trial. JOURNAL OF CLINICAL PSYCHIATRY, 67(3), 400-406.
  
• Predictors of recurrence in bipolar disorder: Primary outcomes from the systematic treatment enhancement program for bipolar disorder (STEP-BD) Perlis, R. H., Ostacher, M. J., Patel, J. K., Marangell, L. B., Zhang, H. W., & Thase, M. E. (2006). Predictors of recurrence in bipolar disorder: Primary outcomes from the systematic treatment enhancement program for bipolar disorder (STEP-BD). AMERICAN JOURNAL OF PSYCHIATRY, 163(2), 217-224.
  
• Treatment-resistant bipolar depression: A STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone Nierenberg, A. A., Ostacher, M. J., Calabrese, J. R., Ketter, T. A., Marangell, L. B., & Sachs, G. S. (2006). Treatment-resistant bipolar depression: A STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. AMERICAN JOURNAL OF PSYCHIATRY, 163(2), 210-216.
  
• Extended-release carbamazepine capsules as monotherapy in bipolar disorder - Pooled results from two randomised, double-blind, placebo-controlled trials Weisler, R. H., Hirschfeld, R., Cutler, A. J., Gazda, T., Ketter, T. A., & Kalali, A. (2006). Extended-release carbamazepine capsules as monotherapy in bipolar disorder - Pooled results from two randomised, double-blind, placebo-controlled trials. CNS DRUGS, 20(3), 219-231.
  
• Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes Ketter, T. A., Houston, J. P., Adams, D. H., Risser, R. C., Meyers, A. L., & Tohen, M. (2006). Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes. JOURNAL OF CLINICAL PSYCHIATRY, 67(1), 95-101.
  
• Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder. Ketter, T. A., Nasrallah, H. A., & Fagiolini, A. (2006). Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder. Psychopharmacology bulletin, 39(1), 120-146.
  
• Clinical use of carbamazepine for bipolar disorders Wang, P. W., & Ketter, T. A. (2005). Clinical use of carbamazepine for bipolar disorders. EXPERT OPINION ON PHARMACOTHERAPY, 6(16), 2887-2902.
  
• Preliminary findings of uncoupling of flow and metabolism in unipolar compared with bipolar affective illness and normal controls Dunn, R. T., Willis, M. W., Benson, B. E., Repella, J. D., Kimbrell, T. A., & Post, R. M. (2005). Preliminary findings of uncoupling of flow and metabolism in unipolar compared with bipolar affective illness and normal controls. PSYCHIATRY RESEARCH-NEUROIMAGING, 140(2), 181-198.
  
• Creativity in familial bipolar disorder Simeonova, D. I., Chang, K. D., Strong, C., & Ketter, T. A. (2005). Creativity in familial bipolar disorder. JOURNAL OF PSYCHIATRIC RESEARCH, 39(6), 623-631.
  
• Cortical magnetic resonance imaging findings in familial pediatric bipolar disorder Chang, K., Barnea-Goraly, N., Karchemskiy, A., Simeonova, D. I., Barnes, P., & Reiss, A. L. (2005). Cortical magnetic resonance imaging findings in familial pediatric bipolar disorder. BIOLOGICAL PSYCHIATRY, 58(3), 197-203.
  
• The Texas Implementation of Medication Algorithms: Update to the algorithms for treatment of bipolar I disorder Suppes, T., Dennehy, E. B., Hirschfeld, R. Ma., Altshuler, L. L., Bowden, C. L., & Swann, A. C. (2005). The Texas Implementation of Medication Algorithms: Update to the algorithms for treatment of bipolar I disorder. JOURNAL OF CLINICAL PSYCHIATRY, 66(7), 870-886.
  
• A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression Calabrese, J. R., Keck, P. E., Macfadden, W., Minkwitz, M., Ketter, T. A., & Mullen, J. (2005). A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. AMERICAN JOURNAL OF PSYCHIATRY, 162(7), 1351-1360.
  
• Reassessing Carbamazepine in the Treatment of Bipolar Disorder Clinical Implications of New Data Ketter, T. A., Akiskal, H. S., Keck, P. E., Fuller, M. A., Weisler, R. H., & Hirschfeld, R. Ma. (2005). Reassessing Carbamazepine in the Treatment of Bipolar Disorder Clinical Implications of New Data. CNS SPECTRUMS, 1-13.
  
• A 12-week randomized open-label study of dermatological precautions with lamotrigine in bipolar disorder patients Graham, J. A., Ketter, T. A., Roberts, J., DeVeaugh-Geiss, A. M., & Thompson, T. R. (2005). A 12-week randomized open-label study of dermatological precautions with lamotrigine in bipolar disorder patients. BIPOLAR DISORDERS, 7, 62-62.
  
• The impact of polarity of subyndromal symptoms in bipolar maintenance studies Yatham, L. N., Bowden, C. L., Calabrese, J. R., Ketter, T. A., Adams, B. E., & Thompson, T. R. (2005). The impact of polarity of subyndromal symptoms in bipolar maintenance studies. BIPOLAR DISORDERS, 7, 113-113.
  
• Olanzapine and lithium prophylaxis of bipolar disorder and episode history Houston, J. P., Ketter, T. A., Risser, R. C., Adams, D. H., Meyers, A., & Tohen, M. (2005). Olanzapine and lithium prophylaxis of bipolar disorder and episode history. BIPOLAR DISORDERS, 7, 66-66.
  
• Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression Keck, P. E., Corya, S. A., Altshuler, L. L., Ketter, T. A., McElroy, S. L., & Tohen, M. (2005). Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression. JOURNAL OF CLINICAL PSYCHIATRY, 66(5), 611-616.
  
• Dermatology precautions and slower titration yield low incidence of lamotrigine treatment-emergent rash Ketter, T. A., Wang, P. W., Chandler, R. A., Alarcon, A. M., Becker, O. V., & Schumacher, M. R. (2005). Dermatology precautions and slower titration yield low incidence of lamotrigine treatment-emergent rash. JOURNAL OF CLINICAL PSYCHIATRY, 66(5), 642-645.
  
• Olanzapine and lithium prophylaxis of bipolar disorder and episode history Ketter, T., Houston, J. P., Risser, R. C., Adams, D. H., Meyers, A., & Tohen, M. (2005). Olanzapine and lithium prophylaxis of bipolar disorder and episode history. BIOLOGICAL PSYCHIATRY, 57(8), 54S-54S.
  
• Temperamental commonalities and differences in euthymic mood disorder patients, creative controls, and healthy controls Nowakowska, C., Strong, C. M., Santosa, C. M., Wang, P. W., & Ketter, T. A. (2005). Temperamental commonalities and differences in euthymic mood disorder patients, creative controls, and healthy controls. JOURNAL OF AFFECTIVE DISORDERS, 85(1-2), 207-215.
  
• Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: A multicenter, randomized, double-blind, placebo-controlled trial Weisler, R. H., Keck, P. E., Swann, A. C., Cutler, A. J., Ketter, T. A., & Kalali, A. H. (2005). Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: A multicenter, randomized, double-blind, placebo-controlled trial. JOURNAL OF CLINICAL PSYCHIATRY, 66(3), 323-330.
  
• Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression Little, J. T., Ketter, T. A., Kimbrell, T. A., Dunn, R. T., Benson, B. E., & Post, R. M. (2005). Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression. BIOLOGICAL PSYCHIATRY, 57(3), 220-228.
  
• Serotonin gene polymorphisms and bipolar I disorder: Focus on the serotonin transporter Mansour, H. A., Talkowski, M. E., Wood, J., Pless, L., Bamne, M., & Nimgaonkar, V. L. (2005). Serotonin gene polymorphisms and bipolar I disorder: Focus on the serotonin transporter. ANNALS OF MEDICINE, 37(8), 590-602.
  
• Demographic and diagnostic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) Kogan, J. N., Otto, M. W., Bauer, M. S., Dennehy, E. B., Miklowitz, D. J., & Sachs, G. S. (2004). Demographic and diagnostic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). BIPOLAR DISORDERS, 6(6), 460-469.
  
• Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania Baker, R. W., Brown, E., Akiskal, H. S., Calabrese, J. R., Ketter, T. A., & Tohen, M. (2004). Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania. BRITISH JOURNAL OF PSYCHIATRY, 185, 472-478.
  
• Lamotrigine therapy in treatment-resistant menstrually-related rapid cycling bipolar disorder: a case report Becker, O. V., Rasgon, N. L., Marsh, W. K., Glenn, T., & Ketter, T. A. (2004). Lamotrigine therapy in treatment-resistant menstrually-related rapid cycling bipolar disorder: a case report. BIPOLAR DISORDERS, 6(5), 435-439.
  
• Phenomenology of rapid-cycling bipolar disorder: Data from the first 500 participants in the systematic treatment enhancement program Schneck, C. D., Miklowitz, D. J., Calabrese, J. R., Allen, M. H., Thomas, M. R., & Sachs, G. S. (2004). Phenomenology of rapid-cycling bipolar disorder: Data from the first 500 participants in the systematic treatment enhancement program. AMERICAN JOURNAL OF PSYCHIATRY, 161(10), 1902-1908.
  
• A potential cholinergic mechanism of procaine's limbic activation Benson, B. E., Carson, R. E., Kiesewetter, D. O., Herscovitch, P., Eckelman, W. C., & Ketter, T. A. (2004). A potential cholinergic mechanism of procaine's limbic activation. NEUROPSYCHOPHARMACOLOGY, 29(7), 1239-1250.
  
• Clinical predictors of response to olanzapine or olanzapine/fluoxetine combination for bipolar depression Tohen, M., Vieta, E., Calabrese, J., Ketter, T., Mitchell, P., & Case, M. (2004). Clinical predictors of response to olanzapine or olanzapine/fluoxetine combination for bipolar depression. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 7, S331-S331.
  
• Sustained remission/euthymia with quetiapine monotherapy for bipolar mania Ketter, T. A., Paulsson, B., & Jones, M. (2004). Sustained remission/euthymia with quetiapine monotherapy for bipolar mania. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 7, S330-S330.
  
• A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes Ketter, T. A., Kalali, A. H., & Weisler, R. H. (2004). A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes. JOURNAL OF CLINICAL PSYCHIATRY, 65(5), 668-673.
  
• Clinical predictors of response to olanzapine or olanzapine/fluoxetine combination for bipolar depression Tohen, M., Vieta, E., Calabrese, J. R., Ketter, T. A., Mitchell, P. B., & Case, M. (2004). Clinical predictors of response to olanzapine or olanzapine/fluoxetine combination for bipolar depression. BIOLOGICAL PSYCHIATRY, 55, 231S-231S.
  
• A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes Weisler, R. H., Kalali, A. H., & Ketter, T. A. (2004). A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. JOURNAL OF CLINICAL PSYCHIATRY, 65(4), 478-484.
  
• Clinical predictors of response to olanzapine or olanzapine/fluoxetine combination for bipolar depression Tohen, M., Vieta, E., Calabrese, J. R., Ketter, T. A., Mitchell, P., & Case, M. (2004). Clinical predictors of response to olanzapine or olanzapine/fluoxetine combination for bipolar depression. EUROPEAN PSYCHIATRY, 19, 204S-204S.
  
• Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP-BD Marangell, L. B., Martinez, J. M., Ketter, T. A., Bowden, C. L., Goldberg, J. F., & Thase, M. E. (2004). Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP-BD. BIPOLAR DISORDERS, 6(2), 139-143.
  
• Psychosocial service utilization by patients with bipolar disorders: data from the first 500 participants in the Systematic Treatment Enhancement Program. Lembke, A., Miklowitz, D. J., Otto, M. W., Zhang, H., Wisniewski, S. R., & Ketter, T. A. (2004). Psychosocial service utilization by patients with bipolar disorders: data from the first 500 participants in the Systematic Treatment Enhancement Program. Journal of psychiatric practice, 10(2), 81-87.
  
• Psychotic bipolar disorders: dimensionally similar to or categorically different from schizophrenia? Ketter, T. A., Wang, P. W., Becker, O. V., Nowakowska, C., & Yang, Y. S. (2004). Psychotic bipolar disorders: dimensionally similar to or categorically different from schizophrenia?. JOURNAL OF PSYCHIATRIC RESEARCH, 38(1), 47-61.
  
• Sustained remission/euthymia with quetiapine monotherapy for bipolar mania Ketter, T. A., Paulsson, B., & Jones, M. (2004). Sustained remission/euthymia with quetiapine monotherapy for bipolar mania. ACTA PSYCHIATRICA SCANDINAVICA, 110, 31-31.
  
• New medication treatment options for bipolar disorders Ketter, T. A., Wang, P. W., Nowakowska, C., & Marsh, W. K. (2004). New medication treatment options for bipolar disorders. ACTA PSYCHIATRICA SCANDINAVICA, 110, 18-33.
  
• New anticonvulsant medication uses in bipolar disorder Wang, P. W., Ketter, T. A., Becker, O. V., & Nowakowska, C. (2003). New anticonvulsant medication uses in bipolar disorder. CNS SPECTRUMS, 8(12), 930-?.
  
• Studies of offspring of parents with bipolar disorder Chang, K., Steiner, H., & Ketter, T. (2003). Studies of offspring of parents with bipolar disorder. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 123C(1), 26-35.
  
• Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression Tohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., & Breier, A. (2003). Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. ARCHIVES OF GENERAL PSYCHIATRY, 60(11), 1079-1088.
  
• Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders Ketter, T. A., Manji, H. K., & Post, R. M. (2003). Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 23(5), 484-495.
  
• Temperament characteristics of child and adolescent bipolar offspring Chang, K. D., Blasey, C. M., Ketter, T. A., & Steiner, H. (2003). Temperament characteristics of child and adolescent bipolar offspring. JOURNAL OF AFFECTIVE DISORDERS, 77(1), 11-19.
  
• Divalproex monotherapy in the treatment of bipolar offspring with mood and behavioral disorders and at least mild affective symptoms Chang, K. D., Dienes, K., Blasey, C., Adleman, N., Ketter, T., & Steiner, H. (2003). Divalproex monotherapy in the treatment of bipolar offspring with mood and behavioral disorders and at least mild affective symptoms. JOURNAL OF CLINICAL PSYCHIATRY, 64(8), 936-942.
  
• Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: A 47-week study Tohen, M., Ketter, T. A., Zarate, C. A., Suppes, T., Frye, M., & Baker, R. W. (2003). Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: A 47-week study. AMERICAN JOURNAL OF PSYCHIATRY, 160(7), 1263-1271.
  
• Bipolar offspring: A window into bipolar disorder evolution Chang, K., Steiner, H., Dienes, K., Adleman, N., & Ketter, T. (2003). Bipolar offspring: A window into bipolar disorder evolution. BIOLOGICAL PSYCHIATRY, 53(11), 945-951.
  
• Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD) Sachs, G. S., Thase, M. E., Otto, M. W., Bauer, M., Miklowitz, D., & Rosenbaum, J. F. (2003). Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). BIOLOGICAL PSYCHIATRY, 53(11), 1028-1042.
  
• Decreased N-acetylaspartate in children with familial bipolar disorder Chang, K., Adleman, N., Dienes, K., Barnea-Goraly, N., Reiss, A., & Ketter, T. (2003). Decreased N-acetylaspartate in children with familial bipolar disorder. BIOLOGICAL PSYCHIATRY, 53(11), 1059-1065.
  
• The diverse roles of anticonvulsants in bipolar disorders. Ketter, T. A., Wang, P. W., Becker, O. V., Nowakowska, C., & Yang, Y.- shou. (2003). The diverse roles of anticonvulsants in bipolar disorders. Annals of clinical psychiatry , 15(2), 95-108.
  
• The emerging differential roles of GABAergic and antiglutamatergic agents in bipolar disorders Ketter, T. A., & Wang, P. W. (2003). The emerging differential roles of GABAergic and antiglutamatergic agents in bipolar disorders. JOURNAL OF CLINICAL PSYCHIATRY, 64, 15-20.
  
• The emerging role of olanzapine in bipolar disorders Ketter, T. A., Wang, P. W., Janenawasin, S., Becker, O. V., & Wang, A. (2002). The emerging role of olanzapine in bipolar disorders. PSYCHIATRIC ANNALS, 32(12), 753-762.
  
• Gabapentin augmentation therapy in bipolar depression Wang, P. W., Santosa, C., Schumacher, M., Winsberg, M. E., Strong, C., & Ketter, T. A. (2002). Gabapentin augmentation therapy in bipolar depression. BIPOLAR DISORDERS, 4(5), 296-301.
  
• Psychiatric uses of antiepileptic treatments Boylan, L. S., Devinsky, O., Barry, J. J., & Ketter, T. A. (2002). Psychiatric uses of antiepileptic treatments. EPILEPSY & BEHAVIOR, 3(5), S54-S59.
  
• Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders Janenawasin, S., Wang, P. W., Lembke, A., Schumacher, M., Das, B., & Ketter, T. A. (2002). Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders. BIPOLAR DISORDERS, 4(5), 328-334.
  
• Automated cerebrum segmentation from three-dimensional sagittal brain MR images Huh, S., Ketter, T. A., Sohn, K. H., & Lee, C. H. (2002). Automated cerebrum segmentation from three-dimensional sagittal brain MR images. COMPUTERS IN BIOLOGY AND MEDICINE, 32(5), 311-328.
  
• Olanzapine versus divalproex in the treatment of acute mania Tohen, M., Baker, R. W., Altshuler, L. L., Zarate, C. A., Suppes, T., & Tollefson, G. A. (2002). Olanzapine versus divalproex in the treatment of acute mania. AMERICAN JOURNAL OF PSYCHIATRY, 159(6), 1011-1017.
  
• Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders? Li, X. H., Ketter, T. A., & Frye, M. A. (2002). Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders?. JOURNAL OF AFFECTIVE DISORDERS, 69(1-3), 1-14.
  
• 3 Tesla 1h-magnetic resonance spectroscopic measurements of prefrontal cortical gamma-aminobutyric acid (GABA) levels in bipolar disorder patients and healthy volunteers Wang, P. W., Dieckmann, N., Sailasuta, N., Adalsteinsson, E., Spielman, D., & Ketter, T. A. (2002). 3 Tesla 1h-magnetic resonance spectroscopic measurements of prefrontal cortical gamma-aminobutyric acid (GABA) levels in bipolar disorder patients and healthy volunteers. BIOLOGICAL PSYCHIATRY, 51(8), 197S-197S.
  
• Principal components of the beck depression inventory and regional cerebral metabolism in unipolar and bipolar depression Dunn, R. T., Kimbrell, T. A., Ketter, T. A., Frye, M. A., Willis, M. W., & Post, R. M. (2002). Principal components of the beck depression inventory and regional cerebral metabolism in unipolar and bipolar depression. BIOLOGICAL PSYCHIATRY, 51(5), 387-399.
  
• Age, sex and laterality effects on cerebral glucose metabolism in healthy adults Willis, M. W., Ketter, T. A., Kimbrell, T. A., George, M. S., Herscovitch, P., & Post, R. M. (2002). Age, sex and laterality effects on cerebral glucose metabolism in healthy adults. PSYCHIATRY RESEARCH-NEUROIMAGING, 114(1), 23-37.
  
• Impaired recognition of facial emotion in mania Lembke, A., & Ketter, T. A. (2002). Impaired recognition of facial emotion in mania. AMERICAN JOURNAL OF PSYCHIATRY, 159(2), 302-304.
  
• Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders Obrocea, G. V., Dunn, R. M., Frye, M. A., Ketter, T. A., Luckenbaugh, D. A., & Post, R. M. (2002). Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders. BIOLOGICAL PSYCHIATRY, 51(3), 253-260.
  
• Regional cerebral glucose utilization in patients with a range of severities of unipolar depression Kimbrell, T. A., Ketter, T. A., George, M. S., Little, J. T., Benson, B. E., & Post, R. M. (2002). Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. BIOLOGICAL PSYCHIATRY, 51(3), 237-252.
  
• Stabilization of mood from below versus above baseline in bipolar disorder: A new nomenclature Ketter, T. A., & Calabrese, J. R. (2002). Stabilization of mood from below versus above baseline in bipolar disorder: A new nomenclature. JOURNAL OF CLINICAL PSYCHIATRY, 63(2), 146-151.
  
• Predictors of treatment response in bipolar disorders: Evidence from clinical and brain imaging studies Ketter, T. A., & Wang, P. W. (2002). Predictors of treatment response in bipolar disorders: Evidence from clinical and brain imaging studies. JOURNAL OF CLINICAL PSYCHIATRY, 63, 21-25.
  
• Pharmacokinetics of mood stabilizers and new anticonvulsants. Wang, P. W., & Ketter, T. A. (2002). Pharmacokinetics of mood stabilizers and new anticonvulsants. Psychopharmacology bulletin, 36(1), 44-66.
  
• Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression Winsberg, M. E., DeGolia, S. G., Strong, C. M., & Ketter, T. A. (2001). Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression. JOURNAL OF AFFECTIVE DISORDERS, 67(1-3), 207-212.
  
• Post-dexamethasone cortisol correlates with severity of depression before and during carbamazepine treatment in women but not men Osuch, E. A., Cora-Locatelli, G., Frye, M. A., Huggins, T., Kimbrell, T. A., & Post, R. M. (2001). Post-dexamethasone cortisol correlates with severity of depression before and during carbamazepine treatment in women but not men. ACTA PSYCHIATRICA SCANDINAVICA, 104(5), 397-401.
  
• 3 Tesla 1H-magnetic resonance spectroscopic (MRS) detection of cerebral gamma-aminobutyric acid (GABA) in bipolar disorder patients and healthy volunteers Wang, P. W., Sachs, N., Sailasuta, N., Adalsteinsson, E., Spielman, D., & Ketter, T. A. (2001). 3 Tesla 1H-magnetic resonance spectroscopic (MRS) detection of cerebral gamma-aminobutyric acid (GABA) in bipolar disorder patients and healthy volunteers. BIOLOGICAL PSYCHIATRY, 49(8), 27S-27S.
  
• Family environment of children and adolescents with bipolar parents Chang, K. D., Blasey, C., Ketter, T. A., & Steiner, H. (2001). Family environment of children and adolescents with bipolar parents. BIPOLAR DISORDERS, 3(2), 73-78.
  
• Special issues in the treatment of paediatric bipolar disorder. Chang, K. D., & Ketter, T. A. (2001). Special issues in the treatment of paediatric bipolar disorder. Expert opinion on pharmacotherapy, 2(4), 613-622.
  
• Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder Ketter, T. A., Kimbrell, T. A., George, M. S., Dunn, R. T., Speer, A. M., & Post, R. M. (2001). Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. BIOLOGICAL PSYCHIATRY, 49(2), 97-109.
  
• A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders Frye, M. A., Ketter, T. A., Kimbrell, T. A., Dunn, R. T., Speer, A. M., & Post, R. M. (2000). A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 20(6), 607-614.
  
• Regional cerebral metabolism associated with anxiety symptoms in affective disorder patients Osuch, E. A., Ketter, T. A., Kimbrell, T. A., George, M. S., Benson, B. E., & Post, R. M. (2000). Regional cerebral metabolism associated with anxiety symptoms in affective disorder patients. BIOLOGICAL PSYCHIATRY, 48(10), 1020-1023.
  
• Biology and recent brain imaging studies in affective psychoses. Wang, P. W., & Ketter, T. A. (2000). Biology and recent brain imaging studies in affective psychoses. Current psychiatry reports, 2(4), 298-304.
  
• Psychiatric phenomenology of child and adolescent bipolar offspring Chang, K. Kd., Steiner, H., & Ketter, T. A. (2000). Psychiatric phenomenology of child and adolescent bipolar offspring. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 39(4), 453-460.
  
• Automated segmentation of the corpus callosum in midsagittal brain magnetic resonance images Lee, C., Huh, S., Ketter, T. A., & Unser, M. (2000). Automated segmentation of the corpus callosum in midsagittal brain magnetic resonance images. OPTICAL ENGINEERING, 39(4), 924-935.
  
• Mood stabilizer augmentation with olanzapine in acutely manic children Chang, K. D., & Ketter, T. A. (2000). Mood stabilizer augmentation with olanzapine in acutely manic children. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 10(1), 45-49.
  
• Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder Winsberg, M. E., Sachs, N., Tate, D. L., Adalsteinsson, E., Spielman, D., & Ketter, T. A. (2000). Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. BIOLOGICAL PSYCHIATRY, 47(6), 475-481.
  
• The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study Frye, M. A., Ketter, T. A., Leverich, G. S., Huggins, T., Lantz, C., & Post, R. M. (2000). The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. JOURNAL OF CLINICAL PSYCHIATRY, 61(1), 9-15.
  
• Baseline cerebral hypermetabolism associated with carbamazepine response, and hypometabolism with nimodipine response in mood disorders Ketter, T. A., Kimbrell, T. A., George, M. S., Willis, M. W., Benson, B. E., & Post, R. M. (1999). Baseline cerebral hypermetabolism associated with carbamazepine response, and hypometabolism with nimodipine response in mood disorders. BIOLOGICAL PSYCHIATRY, 46(10), 1364-1374.
  
• Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders Ketter, T. A., Post, R. M., & Theodore, W. H. (1999). Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. NEUROLOGY, 53(5), S53-S67.
  
• Regional brain activity during transient self-induced anxiety and anger in healthy adults Kimbrell, T. A., George, M. S., Parekh, P. I., Ketter, T. A., Podell, D. M., & Post, R. M. (1999). Regional brain activity during transient self-induced anxiety and anger in healthy adults. BIOLOGICAL PSYCHIATRY, 46(4), 454-465.
  
• Metabolism and excretion of mood stabilizers and new anticonvulsants Ketter, T. A., Frye, M. A., Cora-Locatelli, G., Kimbrell, T. A., & Post, R. M. (1999). Metabolism and excretion of mood stabilizers and new anticonvulsants. CELLULAR AND MOLECULAR NEUROBIOLOGY, 19(4), 511-532.
  
• Differences in dorsolateral prefrontal cortex N-acetyl aspartate in bipolar disorder subtypes using 1H MRS Winsberg, M. E., Sachs, N., Tate, D. L., Spielman, D. M., & Ketter, T. A. (1999). Differences in dorsolateral prefrontal cortex N-acetyl aspartate in bipolar disorder subtypes using 1H MRS. BIOLOGICAL PSYCHIATRY, 45(8), 125S-125S.
  
• Venlafaxine but not bupropion decreases cerebrospinal fluid 5-hydroxyindoleacetic acid in unipolar depression Little, J. T., Ketter, T. A., Mathe, A. A., Frye, M. A., Luckenbaugh, D., & Post, R. M. (1999). Venlafaxine but not bupropion decreases cerebrospinal fluid 5-hydroxyindoleacetic acid in unipolar depression. BIOLOGICAL PSYCHIATRY, 45(3), 285-289.
  
• Gabapentin does not alter single-dose lithium pharmacokinetics Frye, M. A., Kimbrell, T. A., Dunn, R. T., Piscitelli, S., Grothe, D., & Ketter, T. A. (1998). Gabapentin does not alter single-dose lithium pharmacokinetics. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 18(6), 461-464.
  
• Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness Pazzaglia, P. J., Post, R. M., Ketter, T. A., Callahan, A. M., Marangell, L. B., & Luckenbaugh, D. (1998). Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 18(5), 404-413.
  
• Unsupervised connectivity-based thresholding segmentation of midsagittal brain MR images Lee, C., Huh, S., Ketter, T. A., & Unser, M. (1998). Unsupervised connectivity-based thresholding segmentation of midsagittal brain MR images. COMPUTERS IN BIOLOGY AND MEDICINE, 28(3), 309-338.
  
• A potential cholinergic mechanism of procaine's limbic activation Benson, B. E., Carson, R. E., Sandoval, W., Linthicum, W. L., Kimbrell, T. A., & Ketter, T. A. (1998). A potential cholinergic mechanism of procaine's limbic activation. BIOLOGICAL PSYCHIATRY, 43, 27S-28S.
  
• Brain imaging studies of treatments in mood disorders Ketter, T. A., Kennedy, S. H., Kimbrell, T. A., Wu, J. C., Sackeim, H. A., & George, M. S. (1998). Brain imaging studies of treatments in mood disorders. BIOLOGICAL PSYCHIATRY, 43, 61S-61S.
  
• Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder Winsberg, M. E., Sachs, N., Tate, D. L., Dunai, M., Strong, C. M., & Ketter, T. A. (1998). Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. BIOLOGICAL PSYCHIATRY, 43, 23S-23S.
  
• Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics Frye, M. A., Ketter, T. A., Altshuler, L. L., Denicoff, K., Dunn, R. T., & Post, R. M. (1998). Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics. JOURNAL OF AFFECTIVE DISORDERS, 48(2-3), 91-104.
  
• Relationships between thyroid hormone and antidepressant responses to total sleep deprivation in mood disorder patients Parekh, P. I., Ketter, T. A., Altshuler, L., Frye, M. A., Callahan, A., & Post, R. M. (1998). Relationships between thyroid hormone and antidepressant responses to total sleep deprivation in mood disorder patients. BIOLOGICAL PSYCHIATRY, 43(5), 392-394.
  
• Rapid efficacy of olanzapine augmentation in nonpsychotic bipolar mixed states Ketter, T. A., Winsberg, M. E., DeGolia, S. G., Dunai, M., Tate, D. L., & Strong, C. M. (1998). Rapid efficacy of olanzapine augmentation in nonpsychotic bipolar mixed states. JOURNAL OF CLINICAL PSYCHIATRY, 59(2), 83-85.
  
• Psychosensory symptoms in bipolar disorder Ali, S. O., Denicoff, K. D., Ketter, T. A., SmithJackson, E. E., & Post, R. M. (1997). Psychosensory symptoms in bipolar disorder. NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY, 10(4), 223-231.
  
• Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients Marangell, L. B., George, M. S., Callahan, A. M., Ketter, T. A., Pazzaglia, P. J., & Post, R. M. (1997). Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients. ARCHIVES OF GENERAL PSYCHIATRY, 54(3), 214-222.
  
• Inverse relationship of peripheral thyrotropin-stimulating hormone levels to brain activity in mood disorders Marangell, L. B., Ketter, T. A., George, M. S., Pazzaglia, P. J., Callahan, A. M., & Post, R. M. (1997). Inverse relationship of peripheral thyrotropin-stimulating hormone levels to brain activity in mood disorders. AMERICAN JOURNAL OF PSYCHIATRY, 154(2), 224-230.
  
• Comparative antidepressant effects of intravenous and intrathecal thyrotropin-releasing hormone: Confounding effects of tolerance and implications for therapeutics Callahan, A. M., Frye, M. A., Marangell, L. B., George, M. S., Ketter, T. A., & Post, R. M. (1997). Comparative antidepressant effects of intravenous and intrathecal thyrotropin-releasing hormone: Confounding effects of tolerance and implications for therapeutics. BIOLOGICAL PSYCHIATRY, 41(3), 264-272.
  
• Blunted left cingulate activation in mood disorder subjects during a response interference task (the stroop) George, M. S., Ketter, T. A., Parekh, P. I., ROSINSKY, N., Ring, H. A., & Post, R. M. (1997). Blunted left cingulate activation in mood disorder subjects during a response interference task (the stroop). JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 9(1), 55-63.
  
• The place of anticonvulsant therapy in bipolar illness Post, R. M., Ketter, T. A., Denicoff, K., Pazzaglia, P. J., Leverich, G. S., & Frye, M. A. (1996). The place of anticonvulsant therapy in bipolar illness. PSYCHOPHARMACOLOGY, 128(2), 115-129.
  
• Gender differences in regional cerebral blood flow during transient self-induced sadness or happiness George, M. S., Ketter, T. A., Parekh, P. I., Herscovitch, P., & Post, R. M. (1996). Gender differences in regional cerebral blood flow during transient self-induced sadness or happiness. BIOLOGICAL PSYCHIATRY, 40(9), 859-871.
  
• Evaluating the clinical significance of drug interactions: A systematic approach Callahan, A. M., Marangell, L. B., & Ketter, T. A. (1996). Evaluating the clinical significance of drug interactions: A systematic approach. HARVARD REVIEW OF PSYCHIATRY, 4(3), 153-158.
  
• Understanding emotional prosody activates right hemisphere regions George, M. S., Parekh, P. I., ROSINSKY, N., Ketter, T. A., Kimbrell, T. A., & Post, R. M. (1996). Understanding emotional prosody activates right hemisphere regions. ARCHIVES OF NEUROLOGY, 53(7), 665-670.
  
• Felbamate monotherapy has stimulant-like effects in patients with epilepsy Ketter, T. A., Malow, B. A., Flamini, R., Ko, D., White, S. R., & Theodore, W. H. (1996). Felbamate monotherapy has stimulant-like effects in patients with epilepsy. EPILEPSY RESEARCH, 23(2), 129-137.
  
• Reply to letter from Swartz on "Mania and lower serum cholesterol levels. Callahan, A. M., Ketter, T. A., CRUMLISH, J., Parekh, P., Brown, D. W., & Post, R. M. (1996). Reply to letter from Swartz on "Mania and lower serum cholesterol levels. Journal of clinical psychopharmacology, 16(1), 95-97.
  
• Rational polypharmacy in the bipolar affective disorders. Post, R. M., Ketter, T. A., Pazzaglia, P. J., Denicoff, K., George, M. S., & Frye, M. (1996). Rational polypharmacy in the bipolar affective disorders. Epilepsy research. Supplement, 11, 153-180.
  
• Automated connectivity-based thresholding segmentation of midsagittal brain MR images Lee, C., Unser, M., & Ketter, T. A. (1996). Automated connectivity-based thresholding segmentation of midsagittal brain MR images. VISUAL COMMUNICATIONS AND IMAGE PROCESSING '96, 2727, 713-724.
  
• Venlafaxine or bupropion responders but not nonresponders show baseline prefrontal and paralimbic hypometabolism compared with controls Little, J. T., Ketter, T. A., Kimbrell, T. A., Danielson, A., Benson, B., & Post, R. M. (1996). Venlafaxine or bupropion responders but not nonresponders show baseline prefrontal and paralimbic hypometabolism compared with controls. PSYCHOPHARMACOLOGY BULLETIN, 32(4), 629-635.
  
• Developmental psychobiology of cyclic affective illness: Implications for early therapeutic intervention Post, R. M., Weiss, S. Rb., Leverich, G. S., George, M. S., Frye, M., & Ketter, T. A. (1996). Developmental psychobiology of cyclic affective illness: Implications for early therapeutic intervention. DEVELOPMENT AND PSYCHOPATHOLOGY, 8(1), 273-305.
  
• Functional brain imaging, limbic function, and affective disorders Ketter, T. A., George, M. S., Kimbrell, T. A., Benson, B. E., & Post, R. M. (1996). Functional brain imaging, limbic function, and affective disorders. NEUROSCIENTIST, 2(1), 55-65.
  
• Functional brain imaging, limbic function, and affective disorders. Ketter TA, George MS, Kimbrell TA, Benson BE, & Post RM. (1996). Functional brain imaging, limbic function, and affective disorders. The Neuroscientist, 1(2).
  
• Anterior paralimbic mediation of procaine-induced emotional and psychosensory experiences Ketter, T. A., Andreason, P. J., George, M. S., Lee, C., Gill, D. S., & Post, R. M. (1996). Anterior paralimbic mediation of procaine-induced emotional and psychosensory experiences. ARCHIVES OF GENERAL PSYCHIATRY, 53(1), 59-69.
  
• THE EMERGING ROLE OF CYTOCHROME-P450 3A IN PSYCHOPHARMACOLOGY Ketter, T. A., Flockhart, D. A., Post, R. M., Denicoff, K., Pazzaglia, P. J., & Callahan, A. M. (1995). THE EMERGING ROLE OF CYTOCHROME-P450 3A IN PSYCHOPHARMACOLOGY. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 15(6), 387-398.
  
• FELBAMATE MONOTHERAPY - IMPLICATIONS FOR ANTIEPILEPTIC DRUG DEVELOPMENT Theodore, W. H., Albert, P., Stertz, B., Malow, B., Ko, D., & Ketter, T. (1995). FELBAMATE MONOTHERAPY - IMPLICATIONS FOR ANTIEPILEPTIC DRUG DEVELOPMENT. EPILEPSIA, 36(11), 1105-1110.
  
• DAILY REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (RTMS) IMPROVES MOOD IN DEPRESSION George, M. S., Wassermann, E. M., Williams, W. A., Callahan, A., Ketter, T. A., & Post, R. M. (1995). DAILY REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (RTMS) IMPROVES MOOD IN DEPRESSION. NEUROREPORT, 6(14), 1853-1856.
  
• CARBAMAZEPINE BUT NOT VALPROATE INDUCES BUPROPION METABOLISM Ketter, T. A., Jenkins, J. B., SCHROEDER, D. H., Pazzaglia, P. J., Marangell, L. B., & Post, R. M. (1995). CARBAMAZEPINE BUT NOT VALPROATE INDUCES BUPROPION METABOLISM. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 15(5), 327-333.
  
• ADDITION OF MONOAMINE-OXIDASE INHIBITORS TO CARBAMAZEPINE - PRELIMINARY EVIDENCE OF SAFETY AND ANTIDEPRESSANT EFFICACY IN TREATMENT-RESISTANT DEPRESSION Ketter, T. A., Post, R. M., Parekh, P. I., & Worthington, K. (1995). ADDITION OF MONOAMINE-OXIDASE INHIBITORS TO CARBAMAZEPINE - PRELIMINARY EVIDENCE OF SAFETY AND ANTIDEPRESSANT EFFICACY IN TREATMENT-RESISTANT DEPRESSION. JOURNAL OF CLINICAL PSYCHIATRY, 56(10), 471-475.
  
• Procaine-induced increases in limbic rCBF correlate positively with increases in occipital and temporal EEG fast activity. Parekh, P. I., Spencer, J. W., George, M. S., Gill, D. S., Ketter, T. A., & Post, R. M. (1995). Procaine-induced increases in limbic rCBF correlate positively with increases in occipital and temporal EEG fast activity. Brain topography, 7(3), 209-216.
  
• BRAIN ACTIVITY DURING TRANSIENT SADNESS AND HAPPINESS IN HEALTHY WOMEN George, M. S., Ketter, T. A., Parekh, P. I., Horwitz, B., Herscovitch, P., & Post, R. M. (1995). BRAIN ACTIVITY DURING TRANSIENT SADNESS AND HAPPINESS IN HEALTHY WOMEN. AMERICAN JOURNAL OF PSYCHIATRY, 152(3), 341-351.
  
• Automatic recognition of corpus callosum from sagittal brain MR images Lee, C., Unser, M., & Ketter, T. A. (1995). Automatic recognition of corpus callosum from sagittal brain MR images. APPLICATIONS OF DIGITAL IMAGE PROCESSING XVIII, 2564, 528-534.
  
• ACTIVATION STUDIES IN MOOD DISORDERS George, M. S., Ketter, T. A., & Post, R. M. (1994). ACTIVATION STUDIES IN MOOD DISORDERS. PSYCHIATRIC ANNALS, 24(12), 648-652.
  
• PRIMARY MOOD DISORDERS - STRUCTURAL AND RESTING FUNCTIONAL-STUDIES Ketter, T. A., George, M. S., Ring, H. A., Pazzaglia, P., Marangell, L., & Post, R. M. (1994). PRIMARY MOOD DISORDERS - STRUCTURAL AND RESTING FUNCTIONAL-STUDIES. PSYCHIATRIC ANNALS, 24(12), 637-642.
  
• SPATIAL ABILITY IN AFFECTIVE-ILLNESS - DIFFERENCES IN REGIONAL BRAIN ACTIVATION DURING A SPATIAL MATCHING TASK (H2O)-O-15 PET) George, M. S., Ketter, T. A., Parekh, P., Gill, D. S., Huggins, T., & Post, R. M. (1994). SPATIAL ABILITY IN AFFECTIVE-ILLNESS - DIFFERENCES IN REGIONAL BRAIN ACTIVATION DURING A SPATIAL MATCHING TASK (H2O)-O-15 PET). NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY, 7(3), 143-153.
  
• ANTICONVULSANT WITHDRAWAL-EMERGENT PSYCHOPATHOLOGY Ketter, T. A., Malow, B. A., Flamini, R., White, S. R., Post, R. M., & Theodore, W. H. (1994). ANTICONVULSANT WITHDRAWAL-EMERGENT PSYCHOPATHOLOGY. NEUROLOGY, 44(1), 55-61.
  
• A GLOBAL APPROACH TO MULTIVARIATE CORRELATION-ANALYSIS OF PET BRAIN IMAGES Lee, C. H., Unser, M., & Ketter, T. A. (1994). A GLOBAL APPROACH TO MULTIVARIATE CORRELATION-ANALYSIS OF PET BRAIN IMAGES. MATHEMATICAL METHODS IN MEDICAL IMAGING III, 2299, 305-315.
  
• Regional brain activity when selecting a response despite interference: An H2 (15) O PET study of the stroop and an emotional stroop. George, M. S., Ketter, T. A., Parekh, P. I., ROSINSKY, N., Ring, H., & Post, R. M. (1994). Regional brain activity when selecting a response despite interference: An H2 (15) O PET study of the stroop and an emotional stroop. Human brain mapping, 1(3), 194-209.
  
• PRELIMINARY CONTROLLED TRIAL OF NIMODIPINE IN ULTRA-RAPID CYCLING AFFECTIVE DYSREGULATION Pazzaglia, P. J., Post, R. M., Ketter, T. A., George, M. S., & Marangell, L. B. (1993). PRELIMINARY CONTROLLED TRIAL OF NIMODIPINE IN ULTRA-RAPID CYCLING AFFECTIVE DYSREGULATION. PSYCHIATRY RESEARCH, 49(3), 257-272.
  
• SPECT AND PET IMAGING IN MOOD DISORDERS George, M. S., Ketter, T. A., & Post, R. M. (1993). SPECT AND PET IMAGING IN MOOD DISORDERS. JOURNAL OF CLINICAL PSYCHIATRY, 54, 6-13.
  
• BRAIN-REGIONS INVOLVED IN RECOGNIZING FACIAL EMOTION OR IDENTITY - AN O-15 PET STUDY George, M. S., Ketter, T. A., Gill, D. S., Haxby, J. V., Ungerleider, L. G., & Post, R. M. (1993). BRAIN-REGIONS INVOLVED IN RECOGNIZING FACIAL EMOTION OR IDENTITY - AN O-15 PET STUDY. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 5(4), 384-394.
  
• ANTIDEPRESSANT RESPONSE TO SLEEP-DEPRIVATION AS A FUNCTION OF TIME INTO DEPRESSIVE EPISODE IN RAPIDLY CYCLING BIPOLAR PATIENTS Gill, D. S., Ketter, T. A., & Post, R. M. (1993). ANTIDEPRESSANT RESPONSE TO SLEEP-DEPRIVATION AS A FUNCTION OF TIME INTO DEPRESSIVE EPISODE IN RAPIDLY CYCLING BIPOLAR PATIENTS. ACTA PSYCHIATRICA SCANDINAVICA, 87(2), 102-109.
  
• NEW DEVELOPMENTS IN THE USE OF ANTICONVULSANTS AS MOOD STABILIZERS Post, R. M., Ketter, T. A., Pazzaglia, P. J., George, M. S., Marangell, L., & Denicoff, K. (1993). NEW DEVELOPMENTS IN THE USE OF ANTICONVULSANTS AS MOOD STABILIZERS. NEUROPSYCHOBIOLOGY, 27(3), 132-137.
  
• CARBAMAZEPINE-INDUCED INCREASES IN TOTAL SERUM-CHOLESTEROL - CLINICAL AND THEORETICAL IMPLICATIONS Brown, D. W., Ketter, T. A., CRUMLISH, J., & Post, R. M. (1992). CARBAMAZEPINE-INDUCED INCREASES IN TOTAL SERUM-CHOLESTEROL - CLINICAL AND THEORETICAL IMPLICATIONS. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 12(6), 431-437.
  
• CEREBRAL METABOLISM AND DEPRESSION IN PATIENTS WITH COMPLEX PARTIAL SEIZURES Bromfield, E. B., Altshuler, L., Leiderman, D. B., Balish, M., Ketter, T. A., & Theodore, W. H. (1992). CEREBRAL METABOLISM AND DEPRESSION IN PATIENTS WITH COMPLEX PARTIAL SEIZURES. ARCHIVES OF NEUROLOGY, 49(6), 617-623.
  
• PRINCIPLES OF CLINICALLY IMPORTANT DRUG-INTERACTIONS WITH CARBAMAZEPINE .2. Ketter, T. A., Post, R. M., & Worthington, K. (1991). PRINCIPLES OF CLINICALLY IMPORTANT DRUG-INTERACTIONS WITH CARBAMAZEPINE .2. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 11(5), 306-312.
  
• PRINCIPLES OF CLINICALLY IMPORTANT DRUG-INTERACTIONS WITH CARBAMAZEPINE .1. Ketter, T. A., Post, R. M., & Worthington, K. (1991). PRINCIPLES OF CLINICALLY IMPORTANT DRUG-INTERACTIONS WITH CARBAMAZEPINE .1. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 11(3), 198-203.
  
• Antiepileptic drugs in affective illness. Clinical and theoretical implications. Post, R. M., Altshuler, L. L., Ketter, T. A., Denicoff, K., & Weiss, S. R. (1991). Antiepileptic drugs in affective illness. Clinical and theoretical implications. Advances in neurology, 55, 239-277.
  
• LACK OF BENEFICIAL-EFFECTS OF L-BACLOFEN IN AFFECTIVE-DISORDER Post, R. M., Ketter, T. A., Joffe, R. T., & KRAMLINGER, K. L. (1991). LACK OF BENEFICIAL-EFFECTS OF L-BACLOFEN IN AFFECTIVE-DISORDER. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 6(4), 197-207.
  
• TREATMENT OF RAPID CYCLING BIPOLAR ILLNESS Post, R. M., Kramlinger, K. G., Altshuler, L. L., Ketter, T., & Denicoff, K. (1990). TREATMENT OF RAPID CYCLING BIPOLAR ILLNESS. PSYCHOPHARMACOLOGY BULLETIN, 26(1), 37-47.
  
• PERSPECTIVES ON THE MECHANISM OF ACTION OF ELECTROCONVULSIVE-THERAPY - ANTICONVULSANT, PEPTIDERGIC, AND C-FOS PROTO-ONCOGENE EFFECTS Nakajima, T., Post, R. M., Pert, A., Ketter, T. A., & Weiss, S. Rb. (1989). PERSPECTIVES ON THE MECHANISM OF ACTION OF ELECTROCONVULSIVE-THERAPY - ANTICONVULSANT, PEPTIDERGIC, AND C-FOS PROTO-ONCOGENE EFFECTS. CONVULSIVE THERAPY, 5(3), 274-295.